Year |
Citation |
Score |
2017 |
Dobrev D, Schaumburg E. Comment on: Nonparametric Tail Risk, Stock Returns, and the Macroeconomy Journal of Financial Econometrics. 15: 388-409. DOI: 10.1093/Jjfinec/Nbx003 |
0.328 |
|
2016 |
Dobrev D, Nesmith TD, Oh DH. Accurate Evaluation of Expected Shortfall for Linear Portfolios with Elliptically Distributed Risk Factors Social Science Research Network. 2016: 1-8. DOI: 10.17016/Feds.2016.065R1 |
0.327 |
|
2014 |
Andersen TG, Dobrev D, Schaumburg E. A robust neighborhood truncation approach to estimation of integrated quarticity Econometric Theory. 30: 3-59. DOI: 10.17016/Ifdp.2012.1078 |
0.569 |
|
2012 |
Andersen TG, Dobrev D, Schaumburg E. Jump-robust volatility estimation using nearest neighbor truncation Journal of Econometrics. 169: 75-93. DOI: 10.1016/J.Jeconom.2012.01.011 |
0.567 |
|
2010 |
Dobrev D, Szerszen PJ. The information content of high-frequency data for estimating equity return models and forecasting risk Social Science Research Network. 2010: 1-42. DOI: 10.2139/Ssrn.1895533 |
0.349 |
|
2007 |
Andersen TG, Bollerslev T, Dobrev D. No-arbitrage semi-martingale restrictions for continuous-time volatility models subject to leverage effects, jumps and i.i.d. noise: Theory and testable distributional implications Journal of Econometrics. 138: 125-180. DOI: 10.1016/J.Jeconom.2006.05.018 |
0.553 |
|
Low-probability matches (unlikely to be authored by this person) |
2017 |
Dobrev D, Schaumburg E. Erratum to Comment on: Nonparametric Tail Risk, Stock Returns, and the Macroeconomy Journal of Financial Econometrics. 15: 507-507. DOI: 10.1093/Jjfinec/Nbx024 |
0.245 |
|
2016 |
Heijman J, Erfanian Abdoust P, Voigt N, Nattel S, Dobrev D. Computational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillation. The Journal of Physiology. 594: 537-53. PMID 26582329 DOI: 10.1113/Jp271404 |
0.223 |
|
2016 |
Nattel S, Dobrev D. Deciphering the fundamental mechanisms of atrial fibrillation: a quest for over a century. Cardiovascular Research. 109: 465-6. PMID 26857417 DOI: 10.1093/Cvr/Cvw028 |
0.216 |
|
2021 |
Nattel S, Sager P, Huser J, Heijman J, Dobrev D. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovascular Research. PMID 33769493 DOI: 10.1093/cvr/cvab093 |
0.212 |
|
2019 |
Heijman J, Dobrev D. Bayesian network analyses in atrial fibrillation - A path to better therapies? International Journal of Cardiology. Heart & Vasculature. 22: 210-211. PMID 30963097 DOI: 10.1016/j.ijcha.2019.02.009 |
0.211 |
|
2008 |
Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications Circulation. Arrhythmia and Electrophysiology. 1: 62-73. PMID 19808395 DOI: 10.1161/Circep.107.754564 |
0.211 |
|
2014 |
Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circulation Research. 114: 1483-99. PMID 24763466 DOI: 10.1161/Circresaha.114.302226 |
0.207 |
|
2015 |
Ferrari R, Bertini M, Blomstrom-Lundqvist C, Dobrev D, Kirchhof P, Pappone C, Ravens U, Tamargo J, Tavazzi L, Vicedomini GG. An update on atrial fibrillation in 2014: From pathophysiology to treatment. International Journal of Cardiology. 203: 22-29. PMID 26490502 DOI: 10.1016/J.Ijcard.2015.10.089 |
0.206 |
|
2013 |
Heijman J, Voigt N, Dobrev D. New directions in antiarrhythmic drug therapy for atrial fibrillation Future Cardiology. 9: 71-88. PMID 23259476 DOI: 10.2217/fca.12.78 |
0.204 |
|
2011 |
Grandi E, Pandit SV, Voigt N, Workman AJ, Dobrev D, Jalife J, Bers DM. Models of Human Atrial Action Potential for Sinus Rhythm and Chronic Atrial Fibrillation Biophysical Journal. 100: 436a. DOI: 10.1016/J.Bpj.2010.12.2571 |
0.202 |
|
2018 |
Heijman J, Guichard JB, Dobrev D, Nattel S. Translational Challenges in Atrial Fibrillation. Circulation Research. 122: 752-773. PMID 29496798 DOI: 10.1161/Circresaha.117.311081 |
0.202 |
|
2009 |
Greiser M, Neuberger HR, Harks E, El-Armouche A, Boknik P, de Haan S, Verheyen F, Verheule S, Schmitz W, Ravens U, Nattel S, Allessie MA, Dobrev D, Schotten U. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. Journal of Molecular and Cellular Cardiology. 46: 385-94. PMID 19100271 DOI: 10.1016/J.Yjmcc.2008.11.012 |
0.201 |
|
2012 |
Voigt N, Dobrev D. Cellular and molecular correlates of ectopic activity in patients with atrial fibrillation Europace. 14. PMID 23104921 DOI: 10.1093/europace/eus282 |
0.2 |
|
2016 |
Schotten U, Dobrev D, Platonov PG, Kottkamp H, Hindricks G. Current controversies in determining the main mechanisms of atrial fibrillation. Journal of Internal Medicine. PMID 26991914 DOI: 10.1111/joim.12492 |
0.199 |
|
2019 |
Grandi E, Dobrev D, Heijman J. Computational modeling: What does it tell us about atrial fibrillation therapy? International Journal of Cardiology. PMID 30803891 DOI: 10.1016/j.ijcard.2019.01.077 |
0.197 |
|
2012 |
Dobrev D, Carlsson L, Nattel S. Novel molecular targets for atrial fibrillation therapy Nature Reviews Drug Discovery. 11: 275-291. PMID 22460122 DOI: 10.1038/Nrd3682 |
0.197 |
|
2020 |
Nattel S, Heijman J, Zhou L, Dobrev D. Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective. Circulation Research. 127: 51-72. PMID 32717172 DOI: 10.1161/Circresaha.120.316363 |
0.193 |
|
2013 |
Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A, Bailleul C, Bax J, Benninger G, Blomstrom-Lundqvist C, Boersma L, Boriani G, Brandes A, Brown H, Brueckmann M, ... ... Dobrev D, et al. Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 15: 1540-56. PMID 23981824 DOI: 10.1093/Europace/Eut232 |
0.193 |
|
2017 |
Ellinwood N, Dobrev D, Morotti S, Grandi E. In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding. Frontiers in Pharmacology. 8: 799. PMID 29163179 DOI: 10.3389/fphar.2017.00799 |
0.193 |
|
2007 |
Wettwer E, Christ T, Dobrev D, Ravens U. Novel anti-arrhythmic agents for the treatment of atrial fibrillation Current Opinion in Pharmacology. 7: 214-218. PMID 17303472 DOI: 10.1016/J.Coph.2006.10.007 |
0.192 |
|
2018 |
Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, ... ... Dobrev D, et al. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 29300976 DOI: 10.1093/Europace/Eux318 |
0.192 |
|
2016 |
Heijman J, Algalarrondo V, Voigt N, Melka J, Wehrens XH, Dobrev D, Nattel S. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. Cardiovascular Research. 109: 467-79. PMID 26705366 DOI: 10.1093/Cvr/Cvv275 |
0.192 |
|
2020 |
Kuenzel S, Klapproth E, Kuenzel K, Piorkowski C, Mayr M, Wagner M, Dobrev D, Rausch J, Ravens U, Weber S, El-Armouche A. PLK2 is a novel regulator of osteopontin-driven fibrosis and diastolic dysfunction in permanent atrial fibrillation European Heart Journal. 41. DOI: 10.1093/ehjci/ehaa946.3671 |
0.192 |
|
2009 |
Christ T, Wettwer E, Voigt N, Hála O, Radicke S, Matschke K, Várro A, Dobrev D, Ravens U. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation British Journal of Pharmacology. 154: 1619-1630. PMID 18536759 DOI: 10.1038/Bjp.2008.209 |
0.192 |
|
2017 |
Dobrev D, Wehrens XH. Calcium-mediated cellular triggered activity in atrial fibrillation. The Journal of Physiology. PMID 28181690 DOI: 10.1113/JP273048 |
0.191 |
|
2019 |
Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nature Reviews. Cardiology. PMID 30792496 DOI: 10.1038/S41569-019-0166-5 |
0.191 |
|
2019 |
Sutanto H, Laudy L, Clerx M, Dobrev D, Crijns HJGM, Heijman J. Maastricht antiarrhythmic drug evaluator (MANTA): a computational tool for better understanding of antiarrhythmic drugs. Pharmacological Research. 104444. PMID 31493513 DOI: 10.1016/j.phrs.2019.104444 |
0.191 |
|
2014 |
Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circulation Research. 114: 1453-68. PMID 24763464 DOI: 10.1161/Circresaha.114.303211 |
0.191 |
|
2015 |
Voigt N, Heijman J, Dobrev D. New antiarrhythmic targets in atrial fibrillation. Future Cardiology. 11: 645-54. PMID 26609872 DOI: 10.2217/fca.15.67 |
0.19 |
|
2018 |
Molina CE, Abu-Taha IH, Wang Q, Roselló-Díez E, Kamler M, Nattel S, Ravens U, Wehrens XHT, Hove-Madsen L, Heijman J, Dobrev D. Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation. Frontiers in Physiology. 9: 1383. PMID 30356673 DOI: 10.3389/Fphys.2018.01383 |
0.189 |
|
2008 |
Dobrev D. New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation Journal of Interventional Cardiac Electrophysiology. 22: 107-110. PMID 18330686 DOI: 10.1007/s10840-007-9195-9 |
0.188 |
|
2010 |
Wehrens XHT, Ather S, Dobrev D. Role of abnormal sarcoplasmic reticulum function in atrial fibrillation Therapy. 7: 147-158. DOI: 10.2217/thy.10.8 |
0.188 |
|
2012 |
Voigt N, Dobrev D. Ion channel remodelling in atrial fibrillation Interventional Cardiology (London). 7: 97-103. |
0.187 |
|
2012 |
Heijman J, Voigt N, Nattel S, Dobrev D. Calcium handling and atrial fibrillation Wiener Medizinische Wochenschrift. 162: 287-291. PMID 22695810 DOI: 10.1007/S10354-012-0109-9 |
0.187 |
|
2006 |
Dobrev D, Ravens U. Do genetics help to better understand the underlying mechanisms of atrial fibrillation? European Heart Journal. 27: 1640-1641. PMID 16760202 DOI: 10.1093/Eurheartj/Ehl076 |
0.187 |
|
2015 |
Schotten U, Hatem S, Ravens U, Jaïs P, Müller FU, Goette A, Rohr S, Antoons G, Pieske B, Scherr D, Oto A, Casadei B, Verheule S, Cartlidge D, Steinmeyer K, ... ... Dobrev D, et al. The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 17: 1457-66. PMID 26364316 DOI: 10.1093/Europace/Euv252 |
0.186 |
|
2015 |
Voigt N, Pearman CM, Dobrev D, Dibb KM. Methods for isolating atrial cells from large mammals and humans. Journal of Molecular and Cellular Cardiology. 86: 187-98. PMID 26186893 DOI: 10.1016/j.yjmcc.2015.07.006 |
0.185 |
|
2021 |
Wang X, Chen X, Dobrev D, Li N. The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation. Pflugers Archiv : European Journal of Physiology. PMID 33511453 DOI: 10.1007/s00424-021-02515-4 |
0.184 |
|
2012 |
Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, ... ... Dobrev D, et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 14: 8-27. PMID 21791573 DOI: 10.1093/Europace/Eur241 |
0.184 |
|
2021 |
Künzel SR, Hoffmann M, Weber S, Künzel K, Kämmerer S, Günscht M, Klapproth E, Rausch JSE, Sadek M, Kolanowski T, Meyer-Roxlau S, Piorkowski C, Tugtekin SM, Rose-John S, Yin X, ... ... Dobrev D, et al. Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation. Circulation Research. PMID 34433292 DOI: 10.1161/CIRCRESAHA.121.319425 |
0.184 |
|
2018 |
Dan GA, Dobrev D. Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging. International Journal of Cardiology. Heart & Vasculature. 21: 11-15. PMID 30225340 DOI: 10.1016/j.ijcha.2018.08.005 |
0.184 |
|
2021 |
Hulsurkar MM, Lahiri SK, Moore O, Moreira LM, Abu-Taha I, Kamler M, Dobrev D, Nattel S, Reilly S, Wehrens XHT. Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation. Circulation. 144: 909-912. PMID 34516304 DOI: 10.1161/CIRCULATIONAHA.121.055373 |
0.183 |
|
2006 |
Ravens U, Wettwer E, Schotten U, Wessel R, Dobrev D. [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers]. Herzschrittmachertherapie & Elektrophysiologie. 17: 64-72. PMID 16786464 DOI: 10.1007/s00399-006-0512-2 |
0.182 |
|
2010 |
Lendeckel U, Dobrev D, Goette A. Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation British Journal of Pharmacology. 159: 1581-1583. PMID 20388187 DOI: 10.1111/j.1476-5381.2010.00675.x |
0.182 |
|
2014 |
Qi XY, Diness JG, Brundel BJ, Zhou XB, Naud P, Wu CT, Huang H, Harada M, Aflaki M, Dobrev D, Grunnet M, Nattel S. Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog. Circulation. 129: 430-40. PMID 24190961 DOI: 10.1161/Circulationaha.113.003019 |
0.182 |
|
2016 |
Nattel S, Dobrev D. Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nature Reviews. Cardiology. PMID 27489190 DOI: 10.1038/Nrcardio.2016.118 |
0.182 |
|
2010 |
Nishida K, Michael G, Dobrev D, Nattel S. Animal models for atrial fibrillation: Clinical insights and scientific opportunities Europace. 12: 160-172. PMID 19875395 DOI: 10.1093/Europace/Eup328 |
0.181 |
|
2021 |
Hulsurkar M, Lahiri S, Moore O, Moreira L, Abu-Taha I, Dobrev D, Reilly S, Nattel S, Wehrens XH. B-PO01-052 ATRIAL-SPECIFIC LKB1 KNOCKDOWN REPRESENTS A NOVEL MOUSE MODEL OF ATRIAL CARDIOMYOPATHY WITH SPONTANEOUS ATRIAL FIBRILLATION Heart Rhythm. 18: S72. DOI: 10.1016/j.hrthm.2021.06.198 |
0.181 |
|
2008 |
Dobrev D, Nattel S. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics Journal of Cardiovascular Pharmacology. 52: 293-299. PMID 18791467 DOI: 10.1097/Fjc.0B013E318171924D |
0.181 |
|
2018 |
Linz D, Elliott AD, Hohl M, Malik V, Schotten U, Dobrev D, Nattel S, Böhm M, Floras J, Lau DH, Sanders P. Role of autonomic nervous system in atrial fibrillation. International Journal of Cardiology. PMID 30497894 DOI: 10.1016/J.Ijcard.2018.11.091 |
0.181 |
|
2004 |
Dobrev D, Christ T, Ravens U. Muscarinic subtype-2 receptor autoantibodies: Actors or bystanders in human atrial fibrillation? European Heart Journal. 25: 1091-1092. PMID 15231365 DOI: 10.1016/J.Ehj.2004.05.001 |
0.18 |
|
2015 |
Heijman J, Voigt N, Ghezelbash S, Schirmer I, Dobrev D. Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation? Journal of Cardiovascular Pharmacology. 66: 515-22. PMID 25830486 DOI: 10.1097/FJC.0000000000000253 |
0.18 |
|
2015 |
Chiang DY, Lebesgue N, Beavers DL, Alsina KM, Damen JM, Voigt N, Dobrev D, Wehrens XH, Scholten A. Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients. Journal of the American College of Cardiology. 65: 163-73. PMID 25593058 DOI: 10.1016/j.jacc.2014.10.042 |
0.178 |
|
2011 |
Grandi E, Pandit SV, Voigt N, Workman AJ, Dobrev D, Jalife J, Bers DM. Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation. Circulation Research. 109: 1055-66. PMID 21921263 DOI: 10.1161/Circresaha.111.253955 |
0.178 |
|
2013 |
Tsuji Y, Dobrev D. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update. Vascular Health and Risk Management. 9: 165-75. PMID 23637539 DOI: 10.2147/VHRM.S43720 |
0.177 |
|
2012 |
Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: Mechanistic insights and therapeutic opportunities European Heart Journal. 33. PMID 22507975 DOI: 10.1093/Eurheartj/Ehs079 |
0.177 |
|
2014 |
Li N, Chiang DY, Wang S, Wang Q, Sun L, Voigt N, Respress JL, Ather S, Skapura DG, Jordan VK, Horrigan FT, Schmitz W, Müller FU, Valderrabano M, Nattel S, ... Dobrev D, et al. Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation. 129: 1276-85. PMID 24398018 DOI: 10.1161/Circulationaha.113.006611 |
0.175 |
|
2003 |
Dobrev D, Wettwer E, Christ T, Ravens U. Electrical remodeling in chronic human atrial fibrillation Herzschrittmachertherapie Und Elektrophysiologie. 14: 72-79. |
0.175 |
|
2011 |
Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation Journal of Clinical Investigation. 121: 2955-2968. PMID 21804195 DOI: 10.1172/Jci46315 |
0.175 |
|
2013 |
Heijman J, Heusch G, Dobrev D. Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillation. Clinical Medicine Insights. Cardiology. 7: 127-40. PMID 23997577 DOI: 10.4137/CMC.S8445 |
0.173 |
|
2017 |
Grandi E, Dobrev D. Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use?: Editorial on: Neef S, Steffens A, Pellicena P, Mustroph J, Lebek S, Ort KR, Schulman H, Maier LS. Improvement of Cardiomyocyte Function by a Novel Pyrimidine-Based CaMKII-Inhibitor. J Mol Cell Cardiol. 2017;in press. Journal of Molecular and Cellular Cardiology. PMID 29079077 DOI: 10.1016/j.yjmcc.2017.10.010 |
0.173 |
|
2015 |
Nattel S, Dobrev D. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing? Journal of Cardiovascular Pharmacology. 66: 409-11. PMID 26371951 DOI: 10.1097/Fjc.0000000000000319 |
0.172 |
|
2014 |
Heijman J, Voigt N, Wehrens XH, Dobrev D. Calcium dysregulation in atrial fibrillation: the role of CaMKII. Frontiers in Pharmacology. 5: 30. PMID 24624086 DOI: 10.3389/fphar.2014.00030 |
0.172 |
|
2006 |
Dobrev D. Electrical remodeling in atrial fibrillation Herz. 31: 108-112. PMID 16738832 DOI: 10.1007/s00059-006-2787-9 |
0.172 |
|
2017 |
Ji Y, Varkevisser R, Opacic D, Bossu A, Kuiper M, Beekman JDM, Yang S, Khan AP, Dobrev D, Voigt N, Wang MZ, Verheule S, Vos MA, Van der Heyden MAG. The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in dedicated goat and dog models. British Journal of Pharmacology. PMID 28542844 DOI: 10.1111/bph.13869 |
0.172 |
|
2010 |
Dobrev D. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target Naunyn-Schmiedeberg's Archives of Pharmacology. 381: 195-206. PMID 19784635 DOI: 10.1007/s00210-009-0457-1 |
0.172 |
|
2017 |
Meyer-Roxlau S, Lämmle S, Opitz A, Künzel S, Joos JP, Neef S, Sekeres K, Sosalla ST, Schöndube F, Alexiou K, Maier LS, Dobrev D, Guan K, Weber S, El-Armouche A. Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillation. Basic Research in Cardiology. 112: 43. PMID 28597249 DOI: 10.1007/s00395-017-0635-0 |
0.172 |
|
2015 |
Kirchhof P, Breithardt G, Bax J, Benninger G, Blomstrom-Lundqvist C, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Calvert M, Christoffels V, Crijns H, Dobrev D, Ellinor P, et al. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 26481149 DOI: 10.1093/Europace/Euv304 |
0.171 |
|
2011 |
Dobrev D, Voigt N, Wehrens XHT. The ryanodine receptor channel as a molecular motif in atrial fibrillation: Pathophysiological and therapeutic implications Cardiovascular Research. 89: 734-743. PMID 20943673 DOI: 10.1093/cvr/cvq324 |
0.171 |
|
2017 |
Ellinwood N, Dobrev D, Morotti S, Grandi E. Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity. Chaos (Woodbury, N.Y.). 27: 093918. PMID 28964116 DOI: 10.1063/1.5000226 |
0.171 |
|
2016 |
Hartmann N, Mason FE, Braun I, Pabel S, Voigt N, Schotola H, Fischer TH, Dobrev D, Danner BC, Renner A, Gummert J, Belardinelli L, Frey N, Maier LS, Hasenfuss G, et al. The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology. Journal of Molecular and Cellular Cardiology. PMID 27056421 DOI: 10.1016/j.yjmcc.2016.03.012 |
0.171 |
|
2012 |
Hatem S, Schotten U, Rohr S, Dobrev D, Ravens U, Goette A, Pieske B, Kockskämper J, Lendeckel U, Casadei B, Kirchhof P, Müller FU, Jais P, Oto A, Camm AJ. The European Network for Translational Research in Atrial Fibrillation Clinical Investigation. 2: 1061-1067. DOI: 10.4155/Cli.12.103 |
0.17 |
|
2017 |
Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, ... ... Dobrev D, et al. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. European Heart Journal. PMID 28057773 DOI: 10.1093/Eurheartj/Ehw559 |
0.17 |
|
2005 |
Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 111: 2025-32. PMID 15851612 DOI: 10.1161/01.Cir.0000162461.67140.4C |
0.17 |
|
2008 |
Breithardt G, Dobrev D, Doll N, Goette A, Hoffmann B, Kirchhof P, Köster I, Kuck KH, Leute A, Meinertz T, Näbauer M, Oeff M, Ravens U, Schuchert A, Sprenger C, et al. The German Competence Network on Atrial Fibrillation (AFNET). Herz. 33: 548-55. PMID 19137244 DOI: 10.1007/S00059-008-3177-2 |
0.168 |
|
2011 |
Dobrev D. Prevention of atrial fibrillation complications with antiarrhythmic drugs: Still an unmet need in clinical practice Expert Opinion On Pharmacotherapy. 12: 1195-1199. PMID 21548721 DOI: 10.1517/14656566.2011.568476 |
0.168 |
|
2010 |
Voigt N, Trausch A, Knaut M, Matschke K, Varró A, Van Wagoner DR, Nattel S, Ravens U, Dobrev D. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circulation. Arrhythmia and Electrophysiology. 3: 472-80. PMID 20657029 DOI: 10.1161/Circep.110.954636 |
0.167 |
|
2021 |
Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, ... Dobrev D, et al. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovascular Research. PMID 34550344 DOI: 10.1093/cvr/cvab292 |
0.167 |
|
2020 |
Hermans ANL, van der Velden RMJ, Gawalko M, Verhaert DVM, Desteghe L, Duncker D, Manninger M, Heidbuchel H, Pisters R, Hemels M, Pison L, Sohaib A, Sultan A, Steven D, Wijtvliet P, ... ... Dobrev D, et al. On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation. Clinical Cardiology. PMID 33030259 DOI: 10.1002/clc.23469 |
0.167 |
|
2021 |
Fabritz L, Crijns HJGM, Guasch E, Goette A, Häusler KG, Kotecha D, Lewalter T, Meyer C, Potpara TS, Rienstra M, Schnabel RB, Willems S, Breithardt G, Camm AJ, Chan A, ... ... Dobrev D, et al. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 33555020 DOI: 10.1093/europace/euaa279 |
0.167 |
|
2021 |
Odening KE, Gomez AM, Dobrev D, Fabritz L, Heinzel FR, Mangoni ME, Molina CE, Sacconi L, Smith G, Stengl M, Thomas D, Zaza A, Remme CA, Heijman J. ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 34313298 DOI: 10.1093/europace/euab142 |
0.167 |
|
2016 |
Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: definition, characterization, and clinical implication. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 27402624 DOI: 10.1093/Europace/Euw161 |
0.167 |
|
2010 |
Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation The Lancet. 375: 1212-1223. PMID 20334907 DOI: 10.1016/S0140-6736(10)60096-7 |
0.167 |
|
2011 |
Voigt N, Makary S, Nattel S, Dobrev D. Voltage-clamp-based methods for the detection of constitutively active acetylcholine-gated I(K,ACh) channels in the diseased heart. Methods in Enzymology. 484: 653-75. PMID 21036255 DOI: 10.1016/B978-0-12-381298-8.00032-0 |
0.166 |
|
2021 |
Linz D, Gawałko M, Sanders P, Penders J, Li N, Nattel S, Dobrev D. Does gut microbiota affect atrial rhythm? Causalities and speculations. European Heart Journal. PMID 34338744 DOI: 10.1093/eurheartj/ehab467 |
0.165 |
|
2012 |
Li N, Wang T, Wang W, Cutler MJ, Wang Q, Voigt N, Rosenbaum DS, Dobrev D, Wehrens XH. Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circulation Research. 110: 465-70. PMID 22158709 DOI: 10.1161/CIRCRESAHA.111.253229 |
0.165 |
|
2012 |
Voigt N, Nattel S, Dobrev D. Proarrhythmic atrial calcium cycling in the diseased heart. Advances in Experimental Medicine and Biology. 740: 1175-1191. PMID 22453988 DOI: 10.1007/978-94-007-2888-2_53 |
0.165 |
|
2010 |
Dobrev D, Wehrens XHT. Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation Trends in Cardiovascular Medicine. 20: 30-34. PMID 20685575 DOI: 10.1016/j.tcm.2010.03.004 |
0.165 |
|
2019 |
Alsina KM, Hulsurkar M, Brandenburg S, Kownatzki-Danger D, Lenz C, Urlaub H, Abu-Taha I, Kamler M, Chiang DY, Lahiri SK, Reynolds JO, Quick AP, Scott L, Word TA, Gelves MD, ... ... Dobrev D, et al. Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation. Circulation. PMID 31185731 DOI: 10.1161/Circulationaha.119.039642 |
0.164 |
|
2018 |
Yao C, Veleva T, Scott L, Cao S, Li L, Chen G, Jeyabal P, Pan X, Alsina KM, Abu-Taha I, Ghezelbash S, Reynolds CL, Shen YH, LeMaire SA, Schmitz W, ... ... Dobrev D, et al. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation. PMID 29802206 DOI: 10.1161/Circulationaha.118.035202 |
0.164 |
|
2019 |
Fender AC, Wakili R, Dobrev D. Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants. Pharmacological Research. 104257. PMID 31054953 DOI: 10.1016/j.phrs.2019.104257 |
0.163 |
|
2017 |
Heijman J, Ghezelbash S, Wehrens XH, Dobrev D. Serine/Threonine Phosphatases in Atrial Fibrillation. Journal of Molecular and Cellular Cardiology. PMID 28077320 DOI: 10.1016/j.yjmcc.2016.12.009 |
0.163 |
|
2013 |
Heijman J, Voigt N, Abu-Taha IH, Dobrev D. Rhythm control of atrial fibrillation in heart failure. Heart Failure Clinics. 9: 407-15, vii-viii. PMID 24054474 DOI: 10.1016/j.hfc.2013.06.001 |
0.162 |
|
2017 |
Heijman J, Ghezelbash S, Dobrev D. Investigational antiarrhythmic agents: promising drugs in early clinical development. Expert Opinion On Investigational Drugs. PMID 28691539 DOI: 10.1080/13543784.2017.1353601 |
0.162 |
|
2012 |
Dobrev D. Is altered atrial microRNA-ome a critical contributor to the pathophysiology of atrial fibrillation? Basic Research in Cardiology. 107. DOI: 10.1007/s00395-012-0284-2 |
0.16 |
|
2016 |
Smith S, Hughes L, Kline CF, Kempton A, Dorn L, Curran J, Makara M, Webb T, Wright P, Voigt N, Binkley PF, Janssen PM, Kilic A, Carnes CA, Dobrev D, et al. Dysfunction of the βII spectrin-based pathway in human heart failure. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00875.2015. PMID 27106045 DOI: 10.1152/Ajpheart.00875.2015 |
0.16 |
|
2013 |
Tsuji Y, Heijman J, Nattel S, Dobrev D. Electrical storm: recent pathophysiological insights and therapeutic consequences. Basic Research in Cardiology. 108: 336. PMID 23429935 DOI: 10.1007/S00395-013-0336-2 |
0.16 |
|
2009 |
Chelu MG, Sarma S, Sood S, Wang S, van Oort RJ, Skapura DG, Li N, Santonastasi M, Müller FU, Schmitz W, Schotten U, Anderson ME, Valderrábano M, Dobrev D, Wehrens XH. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. The Journal of Clinical Investigation. 119: 1940-51. PMID 19603549 DOI: 10.1172/JCI37059 |
0.159 |
|
2014 |
Chiang DY, Li N, Wang Q, Alsina KM, Quick AP, Reynolds JO, Wang G, Skapura D, Voigt N, Dobrev D, Wehrens XH. Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation. Cardiovascular Research. 103: 178-87. PMID 24812280 DOI: 10.1093/cvr/cvu123 |
0.159 |
|
2020 |
Heijman J, Muna AP, Veleva T, Molina CE, Sutanto H, Tekook MA, Wang Q, Abu-Taha I, Gorka M, Künzel S, El-Armouche A, Reichenspurner H, Kamler M, Nikolaev VO, Ravens U, ... ... Dobrev D, et al. Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Post-Operative Atrial Fibrillation. Circulation Research. PMID 32762493 DOI: 10.1161/Circresaha.120.316710 |
0.159 |
|
2015 |
Glasscock E, Voigt N, McCauley MD, Sun Q, Li N, Chiang DY, Zhou XB, Molina CE, Thomas D, Schmidt C, Skapura DG, Noebels JL, Dobrev D, Wehrens XH. Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation. Basic Research in Cardiology. 110: 505. PMID 26162324 DOI: 10.1007/S00395-015-0505-6 |
0.159 |
|
2004 |
Christ T, Rauwolf T, Braun M, Dobrev D, Ravens U, Strasser RH. Recording atrial monophasic action potentials using standard pacemaker leads: an alternative way to study electrophysiology properties of the human atrium in vivo? Pacing and Clinical Electrophysiology. 27: 1632-1637. PMID 15613126 DOI: 10.1111/J.1540-8159.2004.00696.X |
0.158 |
|
2020 |
Nedios S, Dobrev D. Electrocardiographic sex-related differences in patients with atrial fibrillation: Do they allow a better risk stratification? International Journal of Cardiology. PMID 32122699 DOI: 10.1016/j.ijcard.2020.02.043 |
0.157 |
|
2012 |
Harada M, Luo X, Qi XY, Tadevosyan A, Maguy A, Ordog B, Ledoux J, Kato T, Naud P, Voigt N, Shi Y, Kamiya K, Murohara T, Kodama I, Tardif JC, ... ... Dobrev D, et al. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation. 126: 2051-64. PMID 22992321 DOI: 10.1161/Circulationaha.112.121830 |
0.157 |
|
2020 |
Liu T, Xiong F, Qi XY, Xiao J, Villeneuve L, Abu-Taha I, Dobrev D, Huang C, Nattel S. Altered calcium-handling produces reentry-promoting action potential alternans in atrial fibrillation-remodeled hearts. Jci Insight. PMID 32255765 DOI: 10.1172/Jci.Insight.133754 |
0.157 |
|
2018 |
Fender AC, Dobrev D. Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation? International Journal of Cardiology. PMID 29958692 DOI: 10.1016/j.ijcard.2018.06.045 |
0.157 |
|
2011 |
Dobrev D, Nattel S. New insights into the molecular basis of atrial fibrillation: Mechanistic and therapeutic implications Cardiovascular Research. 89: 689-691. PMID 21296897 DOI: 10.1093/Cvr/Cvr021 |
0.156 |
|
2016 |
Li N, Dobrev D, Wehrens XH. PITX2: a master regulator of cardiac channelopathy in atrial fibrillation? Cardiovascular Research. PMID 26782118 DOI: 10.1093/cvr/cvw008 |
0.156 |
|
2020 |
Berlin S, Goette A, Summo L, Lossie J, Gebauer A, Al-Saady N, Calo L, Naccarelli G, Schunck WH, Fischer R, Camm AJ, Dobrev D. Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study. International Journal of Cardiology. Heart & Vasculature. 29: 100573. PMID 32685659 DOI: 10.1016/j.ijcha.2020.100573 |
0.156 |
|
2021 |
Ni L, Lahiri SK, Nie J, Pan X, Abu-Taha I, Reynolds JO, Campbell HM, Wang H, Kamler M, Schmitz W, Müller FU, Li N, Wei X, Wang DW, Dobrev D, et al. Genetic inhibition of Nuclear Factor of Activated T-cell c2 (NFATc2) prevents atrial fibrillation in CREM transgenic mice. Cardiovascular Research. PMID 34648001 DOI: 10.1093/cvr/cvab325 |
0.155 |
|
2005 |
Gaborit N, Steenman M, Lamirault G, Meur NL, Bouter SL, Lande G, Léger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation. 112: 471-481. PMID 16027256 DOI: 10.1161/Circulationaha.104.506857 |
0.155 |
|
2018 |
Linz D, Hohl M, Dobrev D. Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs? International Journal of Cardiology. Heart & Vasculature. 19: 100-101. PMID 29955670 DOI: 10.1016/j.ijcha.2018.05.006 |
0.154 |
|
2015 |
Qi XY, Huang H, Ordog B, Luo X, Naud P, Sun Y, Wu CT, Dawson K, Tadevosyan A, Chen Y, Harada M, Dobrev D, Nattel S. Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling. Circulation Research. 116: 836-45. PMID 25608527 DOI: 10.1161/Circresaha.116.305326 |
0.154 |
|
2009 |
Michael G, Xiao L, Qi XY, Dobrev D, Nattel S. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. Cardiovascular Research. 81: 491-9. PMID 18826964 DOI: 10.1093/Cvr/Cvn266 |
0.154 |
|
2012 |
Goette A, Hammwöhner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, Dobrev D, Ravens U, Weinert S, Medunjanin S, Lendeckel U, Bode-Böger SM. The impact of rapid atrial pacing on ADMA and endothelial NOS International Journal of Cardiology. 154: 141-146. PMID 20926145 DOI: 10.1016/J.Ijcard.2010.09.004 |
0.153 |
|
2015 |
Heijman J, Dobrev D. Irregular rhythm and atrial metabolism are key for the evolution of proarrhythmic atrial remodeling in atrial fibrillation. Basic Research in Cardiology. 110: 41. PMID 26018792 DOI: 10.1007/s00395-015-0498-1 |
0.153 |
|
2016 |
Molina CE, Heijman J, Dobrev D. Differences in Left Versus Right Ventricular Electrophysiological Properties in Cardiac Dysfunction and Arrhythmogenesis. Arrhythmia & Electrophysiology Review. 5: 14-9. PMID 27403288 DOI: 10.15420/aer.2016.8.2 |
0.153 |
|
2004 |
Dobrev D. Molecular basis of remodelling in atrial fibrillation Deutsche Medizinische Wochenschrift. 129: 827-830. PMID 15054689 DOI: 10.1055/s-2004-822881 |
0.152 |
|
2019 |
Dobrev D. Atrial Ca/calmodulin-dependent Protein Kinase-II: a Druggable Master Switch of Atrial Fibrillation-Associated Atrial Remodeling? Heart Rhythm. PMID 30735791 DOI: 10.1016/j.hrthm.2019.02.002 |
0.152 |
|
2021 |
Trosclair K, Si M, Watts M, Gautier NM, Voigt N, Traylor J, Bitay M, Baczko I, Dobrev D, Hamilton KA, Bhuiyan MS, Dominic P, Glasscock E. Kv1.1 potassium channel subunit deficiency alters ventricular arrhythmia susceptibility, contractility, and repolarization. Physiological Reports. 9: e14702. PMID 33427415 DOI: 10.14814/phy2.14702 |
0.152 |
|
2004 |
Wettwer E, Hála O, Christ T, Heubach JF, Dobrev D, Knaut M, Varró A, Ravens U. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation. 110: 2299-2306. PMID 15477405 DOI: 10.1161/01.Cir.0000145155.60288.71 |
0.152 |
|
2020 |
Campbell HM, Quick AP, Abu-Taha I, Chiang DY, Kramm CF, Word TA, Brandenburg S, Hulsurkar M, Alsina KM, Liu HB, Martin B, Uhlenkamp D, Moore OM, Lahiri SK, Corradini E, ... ... Dobrev D, et al. Loss of SPEG Inhibitory Phosphorylation of RyR2 Promotes Atrial Fibrillation. Circulation. PMID 32683896 DOI: 10.1161/Circulationaha.120.045791 |
0.151 |
|
2017 |
Wakili R, Dobrev D. Role of triggers and substrate in heart failure based atrial fibrillation: Is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy? International Journal of Cardiology. 243: 276-278. PMID 28747031 DOI: 10.1016/j.ijcard.2017.03.111 |
0.151 |
|
2020 |
Kozieł M, Simovic S, Pavlovic N, Nedeljkovic M, Paparisto V, Music L, Goshev E, Dan AR, Manola S, Kusljugic Z, Trendafilova E, Dobrev D, Dan GA, Lip GYH, Potpara TS, et al. Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey. International Journal of Cardiology. Heart & Vasculature. 26: 100461. PMID 32140551 DOI: 10.1016/j.ijcha.2019.100461 |
0.151 |
|
2003 |
Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation Basic Research in Cardiology. 98: 137-148. PMID 12883831 DOI: 10.1007/S00395-003-0409-8 |
0.15 |
|
2015 |
Ravens U, Katircioglu-Öztürk D, Wettwer E, Christ T, Dobrev D, Voigt N, Poulet C, Loose S, Simon J, Stein A, Matschke K, Knaut M, Oto E, Oto A, Güvenir HA. Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillation. Medical & Biological Engineering & Computing. 53: 263-73. PMID 25466224 DOI: 10.1007/S11517-014-1232-0 |
0.15 |
|
2011 |
Cunha SR, Hund TJ, Hashemi S, Voigt N, Li N, Wright P, Koval O, Li J, Gudmundsson H, Gumina RJ, Karck M, Schott JJ, Probst V, Le Marec H, Anderson ME, ... Dobrev D, et al. Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. Circulation. 124: 1212-22. PMID 21859974 DOI: 10.1161/Circulationaha.111.023986 |
0.15 |
|
2011 |
Makary S, Voigt N, Maguy A, Wakili R, Nishida K, Harada M, Dobrev D, Nattel S. Differential Protein Kinase C Isoform Regulation and Increased Constitutive Activity of Acetylcholine-Regulated Potassium Channels in Atrial Remodeling Circulation Research. 109: 1031-1043. PMID 21903936 DOI: 10.1161/Circresaha.111.253120 |
0.149 |
|
2001 |
Dobrev D, Graf E, Wettwer E, Himmel HM, Hála O, Doerfel C, Christ T, Schüler S, Ravens U. Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials. Circulation. 104: 2551-7. PMID 11714649 DOI: 10.1161/Hc4601.099466 |
0.149 |
|
2014 |
Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M, Wehrens XH, Nattel S, Dobrev D. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation. 129: 145-56. PMID 24249718 DOI: 10.1161/Circulationaha.113.006641 |
0.149 |
|
2021 |
Gawałko M, Linz D, Dobrev D. Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation? International Journal of Cardiology. Heart & Vasculature. 34: 100818. PMID 34189250 DOI: 10.1016/j.ijcha.2021.100818 |
0.149 |
|
2018 |
Heijman J, Dobrev D, Crijns HJGM. Electrocardiographic characteristics associated with atrial fibrillation - What do they tell us? International Journal of Cardiology. 266: 143-144. PMID 29887430 DOI: 10.1016/j.ijcard.2018.04.071 |
0.149 |
|
2013 |
Nattel S, Voigt N, Dobrev D. The Molecular Pathophysiology of Atrial Fibrillation Cardiac Electrophysiology: From Cell to Bedside: Sixth Edition. 449-458. DOI: 10.1016/B978-1-4557-2856-5.00045-5 |
0.148 |
|
2018 |
Chen G, Chelu MG, Dobrev D, Li N. Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications. Frontiers in Physiology. 9: 1115. PMID 30150941 DOI: 10.3389/fphys.2018.01115 |
0.148 |
|
2019 |
Mujović N, Dobrev D, Marinković M, Russo V, Potpara TS. The role of amiodarone in contemporary management of complex cardiac arrhythmias. Pharmacological Research. 151: 104521. PMID 31756386 DOI: 10.1016/j.phrs.2019.104521 |
0.148 |
|
2008 |
Yeh YH, Wakili R, Qi XY, Chartier D, Boknik P, Kääb S, Ravens U, Coutu P, Dobrev D, Nattel S. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circulation. Arrhythmia and Electrophysiology. 1: 93-102. PMID 19808399 DOI: 10.1161/Circep.107.754788 |
0.147 |
|
2013 |
Dawson K, Wakili R, Ordög B, Clauss S, Chen Y, Iwasaki Y, Voigt N, Qi XY, Sinner MF, Dobrev D, Kääb S, Nattel S. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation. 127: 1466-75, 1475e1-28. PMID 23459615 DOI: 10.1161/Circulationaha.112.001207 |
0.147 |
|
2016 |
Heijman J, Qi XY, Dobrev D, Nattel S. Computational Analysis of Heart-Failure-Related Remodeling of Cytosolic and Nuclear Calcium Handling in the Canine Atrial Cardiomyocyte Biophysical Journal. 110: 4-5. DOI: 10.1016/J.Bpj.2015.11.2345 |
0.147 |
|
2018 |
Dobrev D, Lorenz K. Age-dependent Increase in JNK2 Activity: Does This Help to Understand CaMKII-mediated Atrial Arrhythmogenesis in Human Atrial Fibrillation? Cardiovascular Research. PMID 29432608 DOI: 10.1093/cvr/cvy037 |
0.147 |
|
2018 |
Scott L, Li N, Dobrev D. Role of inflammatory signaling in atrial fibrillation. International Journal of Cardiology. PMID 30316645 DOI: 10.1016/j.ijcard.2018.10.020 |
0.147 |
|
2009 |
Voigt N, Trausch A, Matschke K, Ravens U, Dobrev D. Presence of Left-to-Right Atrial Inward Rectifier Potassium Current Gradient in Patients with Paroxysmal but Not Chronic Atrial Fibrillation Heart Rhythm. 6: 1691-1692. DOI: 10.1016/J.Hrthm.2009.09.049 |
0.147 |
|
2009 |
Dobrev D, Goette A, Ravens U. Stroke prevention versus bleeding risk of vitamin-k antagonists: A double-edged sword in patients with atrial fibrillation who require surgery Cardiovascular Therapeutics. 27: 223-225. PMID 19903184 DOI: 10.1111/J.1755-5922.2009.00110.X |
0.147 |
|
2013 |
Beavers DL, Wang W, Ather S, Voigt N, Garbino A, Dixit SS, Landstrom AP, Li N, Wang Q, Olivotto I, Dobrev D, Ackerman MJ, Wehrens XH. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. Journal of the American College of Cardiology. 62: 2010-9. PMID 23973696 DOI: 10.1016/j.jacc.2013.06.052 |
0.146 |
|
2007 |
Dobrev D. 5-Hydroxytryptamine and atrial arrhythmogenesis: A "culprit mechanism" or bystander in patients with chronic atrial fibrillation? Journal of Molecular and Cellular Cardiology. 42: 51-53. PMID 17064728 DOI: 10.1016/j.yjmcc.2006.09.014 |
0.146 |
|
2021 |
Fender AC, Dobrev D. The virtual patient - Estimating the health utility of aspirin in simulated populations. International Journal of Cardiology. Heart & Vasculature. 36: 100857. PMID 34458557 DOI: 10.1016/j.ijcha.2021.100857 |
0.146 |
|
2019 |
Goette A, Auricchio A, Boriani G, Braunschweig F, Terradellas JB, Burri H, Camm AJ, Crijns H, Dagres N, Deharo JC, Dobrev D, Hatala R, Hindricks G, Hohnloser SH, Leclercq C, et al. EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 30882143 DOI: 10.1093/europace/euz055 |
0.146 |
|
2005 |
Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U. The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation Circulation. 112: 3697-3706. PMID 16330682 DOI: 10.1161/Circulationaha.105.575332 |
0.145 |
|
2020 |
Reil JC, Reil GH, Kovács Á, Sequeira V, Waddingham MT, Lodi M, Herwig M, Ghaderi S, Kreusser MM, Papp Z, Voigt N, Dobrev D, Meyhöfer S, Langer HF, Maier LS, et al. CaMKII activity contributes to homeometric autoregulation of the heart: a novel mechanism for the Anrep effect. The Journal of Physiology. PMID 32394454 DOI: 10.1113/JP279607 |
0.145 |
|
2007 |
Voigt N, Maguy A, Yeh Y, Qi X, Ravens U, Dobrev D, Nattel S. Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovascular Research. 77: 35-43. PMID 18006448 DOI: 10.1093/Cvr/Cvm051 |
0.144 |
|
2006 |
Ravens U, Dobrev D, Goette A. New aspects in the treatment of atrial fibrillation Herzschrittmachertherapie Und Elektrophysiologie. 17: 61-63. PMID 16786463 DOI: 10.1007/S00399-006-0511-3 |
0.144 |
|
2017 |
Nattel S, Dobrev D. Controversies About Atrial Fibrillation Mechanisms: Aiming for Order in Chaos and Whether it Matters. Circulation Research. 120: 1396-1398. PMID 28450363 DOI: 10.1161/Circresaha.116.310489 |
0.144 |
|
2013 |
Voigt N, Zhou XB, Dobrev D. Isolation of human atrial myocytes for simultaneous measurements of Ca2+ transients and membrane currents. Journal of Visualized Experiments : Jove. e50235. PMID 23852392 DOI: 10.3791/50235 |
0.143 |
|
2020 |
Gawałko M, Kapłon-Cieślicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. International Journal of Cardiology. Heart & Vasculature. 30: 100631. PMID 32904969 DOI: 10.1016/j.ijcha.2020.100631 |
0.143 |
|
2019 |
Grandi E, Dobrev D. Atrial fibrillation in a dish: Insights into atrial arrhythmogenesis from induced pluripotent stem cell derived cardiomyocytes. Cardiovascular Research. PMID 31860074 DOI: 10.1093/cvr/cvz342 |
0.143 |
|
2018 |
Li N, Dobrev D. Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure? Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 29327256 DOI: 10.1007/s00210-018-1463-y |
0.142 |
|
2015 |
Chiang DY, Zhang M, Voigt N, Alsina KM, Jakob H, Martin JF, Dobrev D, Wehrens XH, Li N. Identification of microRNA-mRNA dysregulations in paroxysmal atrial fibrillation. International Journal of Cardiology. 184: 190-7. PMID 25706326 DOI: 10.1016/j.ijcard.2015.01.075 |
0.142 |
|
2010 |
Wakili R, Yeh Y, Qi XY, Greiser M, Chartier D, Nishida K, Maguy A, Villeneuve L, Boknik P, Voigt N, Krysiak J, Kääb S, Ravens U, Linke WA, Stienen GJM, ... ... Dobrev D, et al. Multiple Potential Molecular Contributors to Atrial Hypocontractility Caused by Atrial Tachycardia Remodeling in Dogs Circulation-Arrhythmia and Electrophysiology. 3: 530-541. PMID 20660541 DOI: 10.1161/Circep.109.933036 |
0.142 |
|
2016 |
Chiang DY, Heck AJ, Dobrev D, Wehrens XH. Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome. Journal of Molecular and Cellular Cardiology. PMID 27663175 DOI: 10.1016/J.Yjmcc.2016.09.009 |
0.142 |
|
2020 |
Campbell H, Aguilar-Sanchez Y, Quick AP, Dobrev D, Wehrens X. SPEG: a key regulator of cardiac calcium homeostasis. Cardiovascular Research. PMID 33067609 DOI: 10.1093/cvr/cvaa290 |
0.142 |
|
2016 |
Chiamvimonvat N, Chen-Izu Y, Clancy CE, Deschenes I, Dobrev D, Heijman J, Izu L, Qu Z, Ripplinger CM, Vandenberg JI, Weiss JN, Koren G, Banyasz T, Grandi E, Sanguinetti MC, et al. Potassium currents in the heart: Functional roles in repolarization, arrhythmia and therapeutics. The Journal of Physiology. PMID 27808412 DOI: 10.1113/Jp272883 |
0.141 |
|
2021 |
Aguilar M, Heijman J, Dobrev D, Nattel S. One ring to rule them all: Continuous monitoring of patients with secondary atrial fibrillation points to a unifying underlying mechanism. The Canadian Journal of Cardiology. PMID 33493661 DOI: 10.1016/j.cjca.2021.01.018 |
0.141 |
|
2017 |
Landstrom AP, Dobrev D, Wehrens XHT. Calcium Signaling and Cardiac Arrhythmias. Circulation Research. 120: 1969-1993. PMID 28596175 DOI: 10.1161/CIRCRESAHA.117.310083 |
0.141 |
|
2013 |
Voigt N, Heijman J, Trausch A, Mintert-Jancke E, Pott L, Ravens U, Dobrev D. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation. Journal of Molecular and Cellular Cardiology. 61: 142-52. PMID 23531443 DOI: 10.1016/J.Yjmcc.2013.03.011 |
0.14 |
|
2015 |
Ghezelbash S, Molina CE, Dobrev D. Altered atrial metabolism: an underappreciated contributor to the initiation and progression of atrial fibrillation. Journal of the American Heart Association. 4: e001808. PMID 25773300 DOI: 10.1161/JAHA.115.001808 |
0.139 |
|
2021 |
Aguilar M, Dobrev D, Nattel S. Postoperative Atrial Fibrillation: Features, Mechanisms, and Clinical Management. Cardiac Electrophysiology Clinics. 13: 123-132. PMID 33516390 DOI: 10.1016/j.ccep.2020.11.010 |
0.139 |
|
2007 |
Dobrev D. Cardiomyocyte Ca2+ overload in atrial tachycardia: Is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis? Naunyn-Schmiedeberg's Archives of Pharmacology. 376: 227-230. PMID 17999053 DOI: 10.1007/s00210-007-0199-x |
0.138 |
|
2018 |
Alsina K, Hulsurkar M, Yao C, Langer B, Chiang D, Buxton S, Sangen Nvd, Heck A, Dobrev D, Wehrens X. Novel role of the protein phosphatase 1 regulatory subunit PPP1R3A in atrial fibrillation Journal of Molecular and Cellular Cardiology. 124: 108. DOI: 10.1016/J.Yjmcc.2018.07.077 |
0.137 |
|
2003 |
Wettwer E, Christ T, Dobrev D, Ravens U. Cardiac cellular electrophysiology Herzschrittmachertherapie Und Elektrophysiologie. 14: 50-60. |
0.137 |
|
2017 |
Yao C, Scott L, Veleva T, Müller FU, Nattel S, Dobrev D, Wehrens XHT, Li N. 039Enhanced Activation of Inflammasome Promotes Atrial Fibrillation Journal of Molecular and Cellular Cardiology. 112: 147. DOI: 10.1016/J.Yjmcc.2017.07.051 |
0.137 |
|
2011 |
Ehrlich JR, Dobrev D. Atrial-selective sodium channel block by dronedarone: Sufficient to terminate atrial fibrillation? Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 109-114. PMID 21541758 DOI: 10.1007/s00210-011-0647-5 |
0.137 |
|
2018 |
Sutanto H, Dobrev D, Heijman J. Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation? Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 30238135 DOI: 10.1007/s00210-018-1566-5 |
0.137 |
|
2015 |
Harada M, Tadevosyan A, Qi X, Xiao J, Liu T, Voigt N, Karck M, Kamler M, Kodama I, Murohara T, Dobrev D, Nattel S. Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression. Journal of the American College of Cardiology. 66: 47-58. PMID 26139058 DOI: 10.1016/J.Jacc.2015.04.056 |
0.136 |
|
2008 |
Sood S, Chelu MG, van Oort RJ, Skapura D, Santonastasi M, Dobrev D, Wehrens XHT. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation Heart Rhythm. 5: 1047-1054. PMID 18598963 DOI: 10.1016/j.hrthm.2008.03.030 |
0.136 |
|
2020 |
Qi XY, Vahdahi Hassani F, Hoffmann D, Xiao J, Xiong F, Villeneuve LR, Ljubojevic-Holzer S, Kamler M, Abu-Taha I, Heijman J, Bers DM, Dobrev D, Nattel S. Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial Fibrillation. Circulation Research. PMID 33375812 DOI: 10.1161/CIRCRESAHA.120.317768 |
0.136 |
|
2021 |
Riesinger L, Wakili R, Dobrev D. Stroke prevention of atrial fibrillation: Improving geographic under-use of contemporary antithrombotic approaches remains a challenge. International Journal of Cardiology. Heart & Vasculature. 34: 100785. PMID 33997258 DOI: 10.1016/j.ijcha.2021.100785 |
0.136 |
|
2013 |
Purohit A, Rokita AG, Guan X, Chen B, Koval OM, Voigt N, Neef S, Sowa T, Gao Z, Luczak ED, Stefansdottir H, Behunin AC, Li N, El-Accaoui RN, Yang B, ... ... Dobrev D, et al. Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation. 128: 1748-57. PMID 24030498 DOI: 10.1161/Circulationaha.113.003313 |
0.135 |
|
2005 |
Ellinghaus P, Scheubel RJ, Dobrev D, Ravens U, Holtz J, Huetter J, Nielsch U, Morawietz H. Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. The Journal of Thoracic and Cardiovascular Surgery. 129: 1383-1390. PMID 15942582 DOI: 10.1016/J.Jtcvs.2004.08.031 |
0.134 |
|
2020 |
Fender AC, Dobrev D. Heart failure with preserved ejection fraction meets atrial fibrillation: is enhanced inflammasome signaling a major common mechanism leading to these two frequent diseases? Heart Rhythm. PMID 32151740 DOI: 10.1016/j.hrthm.2020.02.032 |
0.134 |
|
2013 |
Heijman J, Dewenter M, El-Armouche A, Dobrev D. Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. Journal of Molecular and Cellular Cardiology. 64: 90-8. PMID 24051368 DOI: 10.1016/j.yjmcc.2013.09.006 |
0.133 |
|
2017 |
Heijman J, Dobrev D, Crijns HJGM. Targeting supraventricular ectopic complexes: Which approach should be used and how does it affect atrial fibrillation? International Journal of Cardiology. 244: 202-203. PMID 28784443 DOI: 10.1016/j.ijcard.2017.06.013 |
0.133 |
|
2015 |
Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, ... ... Dobrev D, et al. Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients with Chronic Atrial Fibrillation. Circulation. PMID 25951834 DOI: 10.1161/CIRCULATIONAHA.114.012657 |
0.133 |
|
2017 |
Chen Y, Surinkaew S, Naud P, Qi XY, Gillis MA, Shi YF, Tardif JC, Dobrev D, Nattel S. JAK-STAT signaling and the atrial fibrillation promoting fibrotic substrate. Cardiovascular Research. PMID 28158495 DOI: 10.1093/Cvr/Cvx004 |
0.132 |
|
2019 |
Sutanto H, Dobrev D, Heijman J. Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci. International Journal of Cardiology. Heart & Vasculature. 24: 100397. PMID 31334334 DOI: 10.1016/j.ijcha.2019.100397 |
0.132 |
|
2010 |
Voigt N, Rozmaritsa N, Trausch A, Zimniak T, Christ T, Wettwer E, Matschke K, Dobrev D, Ravens U. Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation Naunyn-Schmiedebergs Archives of Pharmacology. 381: 251-259. PMID 19760273 DOI: 10.1007/S00210-009-0452-6 |
0.132 |
|
2012 |
Heijman J, Dobrev D. Systems approaches to post-operative atrial fibrillation - Do they help us to better understand the ionic basis of the arrhythmogenic substrate? Journal of Molecular and Cellular Cardiology. 53: 320-322. PMID 22742961 DOI: 10.1016/j.yjmcc.2012.06.005 |
0.13 |
|
2000 |
Ravens U, Dobrev D. Regulation of sarcoplasmic reticulum Ca2+-ATPase and phospholamban in the failing and nonfailing heart Cardiovascular Research. 45: 245-252. PMID 10728342 DOI: 10.1016/S0008-6363(99)00338-7 |
0.13 |
|
2017 |
Fender AC, Dobrev D. Dynamic balance of platelet reactivity in atrial fibrillation PARtially unravelled. International Journal of Cardiology. 243: 272-273. PMID 28747029 DOI: 10.1016/j.ijcard.2017.04.074 |
0.13 |
|
2004 |
Christ T, Boknik P, Wöhrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D. L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation. 110: 2651-7. PMID 15492323 DOI: 10.1161/01.Cir.0000145659.80212.6A |
0.129 |
|
2016 |
Heijman J, Dobrev D. Challenges to the translation of basic science findings to atrial fibrillation therapies. Future Cardiology. PMID 27091233 DOI: 10.2217/fca-2016-0007 |
0.129 |
|
2021 |
Sutanto H, Dobrev D, Heijman J. Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias. International Journal of Molecular Sciences. 22. PMID 34445698 DOI: 10.3390/ijms22168994 |
0.129 |
|
2019 |
Fender AC, Dobrev D. One for all and all for one? The dilemma of optimal management of atrial fibrillation with cardiac co-morbidities. International Journal of Cardiology. PMID 31611083 DOI: 10.1016/j.ijcard.2019.10.010 |
0.128 |
|
2021 |
Nattel S, Lip GYH, Filgueiras-Rama D, Dobrev D. Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation. Cardiovascular Research. PMID 34086918 DOI: 10.1093/cvr/cvab170 |
0.128 |
|
2006 |
El-Armouche A, Knaut M, Eschenhagen T, Ravens U, Dobrev D. Phospholamban and troponin I phosphorylation in remodeled left atria from patients with sinus rhythm and chronic atrial fibrillation Journal of Molecular and Cellular Cardiology. 40: 927. DOI: 10.1016/J.Yjmcc.2006.03.035 |
0.128 |
|
2017 |
Molina CE, Jacquet E, Ponien P, Muñoz-Guijosa C, Baczkó I, Maier LS, Donzeau-Gouge P, Dobrev D, Fischmeister R, Garnier A. Identification of optimal reference genes for transcriptomic analyses in normal and diseased human heart. Cardiovascular Research. PMID 29036603 DOI: 10.1093/cvr/cvx182 |
0.126 |
|
2021 |
Gawałko M, Dobrev D. Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence? International Journal of Cardiology. Heart & Vasculature. 32: 100693. PMID 33426267 DOI: 10.1016/j.ijcha.2020.100693 |
0.126 |
|
2014 |
Voigt N, Abu-Taha I, Heijman J, Dobrev D. Constitutive activity of the acetylcholine-activated potassium current IK,ACh in cardiomyocytes. Advances in Pharmacology (San Diego, Calif.). 70: 393-409. PMID 24931203 DOI: 10.1016/B978-0-12-417197-8.00013-4 |
0.125 |
|
2015 |
Smith SA, Sturm AC, Curran J, Kline CF, Little SC, Bonilla IM, Long VP, Makara M, Polina I, Hughes LD, Webb TR, Wei Z, Wright P, Voigt N, Bhakta D, ... ... Dobrev D, et al. Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia. Circulation. 131: 695-708. PMID 25632041 DOI: 10.1161/Circulationaha.114.013708 |
0.124 |
|
2017 |
Meyer-Roxlau S, Lämmle S, Opitz A, Künzel S, Joos JP, Neef S, Sekeres K, Sossalla S, Schöndube F, Alexiou K, Maier LS, Dobrev D, Guan K, Weber S, El-Armouche A. Erratum to: Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillation. Basic Research in Cardiology. 112: 51. PMID 28688054 DOI: 10.1007/s00395-017-0638-x |
0.123 |
|
2011 |
Tsuji Y, Hojo M, Voigt N, El-Armouche A, Inden Y, Murohara T, Dobrev D, Nattel S, Kodama I, Kamiya K. Ca2+-Related Signaling and Protein Phosphorylation Abnormalities Play Central Roles in a New Experimental Model of Electrical Storm Circulation. 123: 2192-2203. PMID 21555709 DOI: 10.1161/Circulationaha.110.016683 |
0.123 |
|
2016 |
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, ... ... Dobrev D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. PMID 27663299 DOI: 10.1093/ejcts/ezw313 |
0.122 |
|
2009 |
Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Röhl FW, Wolke C, Bergmann S, Bramlage P, Ravens U, Lendeckel U. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. European Heart Journal. 30: 1411-20. PMID 19269986 DOI: 10.1093/Eurheartj/Ehp046 |
0.122 |
|
2013 |
Guasch E, Benito B, Qi X, Cifelli C, Naud P, Shi Y, Mighiu A, Tardif JC, Tadevosyan A, Chen Y, Gillis MA, Iwasaki YK, Dobrev D, Mont L, Heximer S, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. Journal of the American College of Cardiology. 62: 68-77. PMID 23583240 DOI: 10.1016/J.Jacc.2013.01.091 |
0.122 |
|
2018 |
Ellinwood N, Dobrev D, Morotti S, Grandi E. In Silico Assessment of Atrial Fibrillation-Selectivity of Ikur Inhibitors: Role of Variability in Disease-Associated Remodeling Biophysical Journal. 114: 473a-474a. DOI: 10.1016/j.bpj.2017.11.2606 |
0.122 |
|
2020 |
Barrios Espinosa C, Hemels MEW, Dobrev D, Heijman J. Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication. International Journal of Cardiology. Heart & Vasculature. 29: 100609. PMID 32885800 DOI: 10.1016/j.ijcha.2020.100609 |
0.121 |
|
2018 |
Dobrev D, Wehrens XHT. Mouse Models of Cardiac Arrhythmias. Circulation Research. 123: 332-334. PMID 30026380 DOI: 10.1161/CIRCRESAHA.118.313406 |
0.12 |
|
2020 |
Sutanto H, Cluitmans MJM, Dobrev D, Volders PGA, Bébarová M, Heijman J. Acute effects of alcohol on cardiac electrophysiology and arrhythmogenesis: Insights from multiscale in silico analyses. Journal of Molecular and Cellular Cardiology. 146: 69-83. PMID 32710981 DOI: 10.1016/j.yjmcc.2020.07.007 |
0.12 |
|
2016 |
Voigt N, Dobrev D. Atrial-Selective Potassium Channel Blockers. Cardiac Electrophysiology Clinics. 8: 411-21. PMID 27261831 DOI: 10.1016/j.ccep.2016.02.005 |
0.12 |
|
2018 |
Dobrev D. Sex-specific density of ventricular SK currents: is this a general feature of SK channel function? The Journal of Physiology. PMID 30019760 DOI: 10.1113/JP276663 |
0.12 |
|
2007 |
Dobrev D, Christ T, Boknik P, Wöhrl S, Bosch R-, Ravens U. Regulation of l-type Ca2+ channels in left atria of patients with chronic atrial fibrillation Journal of Molecular and Cellular Cardiology. 42. DOI: 10.1016/J.Yjmcc.2007.03.058 |
0.12 |
|
2004 |
Christ T, Wüst M, Matthes J, Jänchen M, Jürgens S, Herzig S, Wettwer E, Dobrev D, Matschke K, Mebs D, Ravens U. An aqueous extract of the marine sponge Ectyoplasia ferox stimulates L-type Ca2+-current by direct interaction with the Cav1.2 subunit. Naunyn-Schmiedeberg's Archives of Pharmacology. 370: 474-83. PMID 15599709 DOI: 10.1007/S00210-004-0996-4 |
0.119 |
|
2021 |
Wagner M, Sadek MS, Dybkova N, Mason FE, Klehr J, Firneburg R, Cachorro E, Richter K, Klapproth E, Kuenzel SR, Lorenz K, Heijman J, Dobrev D, El-Armouche A, Sossalla S, et al. Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression. International Journal of Molecular Sciences. 22. PMID 34062838 DOI: 10.3390/ijms22094816 |
0.119 |
|
2013 |
Heijman J, Wehrens XHT, Dobrev D. Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia - is there a mechanistic link between sarcoplasmic reticulum Ca2+ leak and re-entry? Acta Physiologica. 207: 208-211. PMID 23157571 DOI: 10.1111/apha.12038 |
0.118 |
|
2002 |
Christ T, Schier M, Brattström A, Muth G, Hartmann A, Dobrev D, Ravens U. Rate-adaptive pacing using intracardiac impedance shows no evidence for positive feedback during dobutamine stress test. Europace. 4: 311-315. PMID 12134978 DOI: 10.1053/Eupc.2002.0235 |
0.118 |
|
2020 |
Fender AC, Dobrev D. Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation. International Journal of Cardiology. Heart & Vasculature. 27: 100487. PMID 32310243 DOI: 10.1016/j.ijcha.2020.100487 |
0.118 |
|
2019 |
Fender AC, Dobrev D. Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome. International Journal of Cardiology. Heart & Vasculature. 22: 214-215. PMID 30963099 DOI: 10.1016/j.ijcha.2019.02.007 |
0.117 |
|
2012 |
Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S, Wehrens XHT, Dobrev D. Enhanced sarcoplasmic reticulum Ca 2+ Leak and increased Na +-Ca 2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation Circulation. 125: 2059-2070. PMID 22456474 DOI: 10.1161/Circulationaha.111.067306 |
0.116 |
|
2015 |
Le Quang K, Maguy A, Qi XY, Naud P, Xiong F, Tadevosyan A, Shi YF, Chartier D, Tardif JC, Dobrev D, Nattel S. Loss of Cardiomyocyte Integrin Linked Kinase Produces an Arrhythmogenic Cardiomyopathy in Mice. Circulation. Arrhythmia and Electrophysiology. PMID 26071395 DOI: 10.1161/Circep.115.001668 |
0.116 |
|
2014 |
Heijman J, Voigt N, Carlsson LG, Dobrev D. Cardiac safety assays. Current Opinion in Pharmacology. 15: 16-21. PMID 24721649 DOI: 10.1016/j.coph.2013.11.004 |
0.116 |
|
2017 |
Heijman J, Dobrev D. Inhibition of Small-Conductance Ca(2+)-Activated K(+) Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation? Circulation. Arrhythmia and Electrophysiology. 10. PMID 29018167 DOI: 10.1161/CIRCEP.117.005776 |
0.115 |
|
2011 |
Richards MA, Clarke JD, Saravanan P, Voigt N, Dobrev D, Eisner DA, Trafford AW, Dibb KM. Transverse tubules are a common feature in large mammalian atrial myocytes including human. American Journal of Physiology. Heart and Circulatory Physiology. 301: H1996-2005. PMID 21841013 DOI: 10.1152/Ajpheart.00284.2011 |
0.115 |
|
2018 |
Fender AC, Dobrev D. The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes. International Journal of Cardiology. PMID 29804702 DOI: 10.1016/j.ijcard.2018.05.064 |
0.114 |
|
2016 |
Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, ... ... Dobrev D, et al. Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation". Circulation. 133: e440-1. PMID 26976923 DOI: 10.1161/CIRCULATIONAHA.115.020662 |
0.114 |
|
2008 |
Qi XY, Yeh Y, Xiao L, Burstein B, Maguy A, Chartier D, Villeneuve LR, Brundel BJJM, Dobrev D, Nattel S. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current Circulation Research. 103: 845-854. PMID 18723446 DOI: 10.1161/Circresaha.108.175463 |
0.113 |
|
2021 |
Scott L, Fender AC, Saljic A, Li L, Chen X, Wang X, Linz D, Lang J, Hohl M, Twomey D, Pham TT, Diaz-Lankenau R, Chelu MG, Kamler M, Entman ML, ... ... Dobrev D, et al. NLRP3 inflammasome is a key driver of Obesity-Induced atrial arrhythmias. Cardiovascular Research. PMID 33523143 DOI: 10.1093/cvr/cvab024 |
0.113 |
|
2019 |
Linz D, Sanders P, Pitman B, Dobrev D, Lau DH. Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns? International Journal of Cardiology. Heart & Vasculature. 22: 212-213. PMID 30963098 DOI: 10.1016/j.ijcha.2019.02.008 |
0.113 |
|
2010 |
Wittköpper K, Fabritz L, Neef S, Ort KR, Grefe C, Unsöld B, Kirchhof P, Maier LS, Hasenfuss G, Dobrev D, Eschenhagen T, El-Armouche A. Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. The Journal of Clinical Investigation. 120: 617-26. PMID 20071777 DOI: 10.1172/JCI40545 |
0.113 |
|
2017 |
Ellinwood N, Dobrev D, Morotti S, Grandi E. Erratum: "Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity" [Chaos 27, 093918 (2017)]. Chaos (Woodbury, N.Y.). 27: 109902. PMID 29092428 DOI: 10.1063/1.5007051 |
0.112 |
|
2019 |
Dobrev D, Potpara TS. Smart device-based detection of atrial fibrillation: Opportunities and challenges in the emerging world of digital health. International Journal of Cardiology. PMID 31870783 DOI: 10.1016/j.ijcard.2019.12.023 |
0.112 |
|
2005 |
Dobrev D, Voigt N, Christ T, Wettwer E, Knaut M, Ravens U. Dynamic regulation of IK,ACh by protein kinases in human atrial myocytes: Influence of chronic atrial fibrillation Heart Rhythm. 2. DOI: 10.1016/J.Hrthm.2005.02.054 |
0.112 |
|
2020 |
Sutanto H, Lyon A, Lumens J, Schotten U, Dobrev D, Heijman J. Cardiomyocyte calcium handling in health and disease: Insights from in vitro and in silico studies. Progress in Biophysics and Molecular Biology. PMID 32188566 DOI: 10.1016/j.pbiomolbio.2020.02.008 |
0.111 |
|
2019 |
Fender AC, Dobrev D. Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer. International Journal of Cardiology. Heart & Vasculature. 23: 100374. PMID 31193086 DOI: 10.1016/j.ijcha.2019.100374 |
0.111 |
|
2016 |
Li N, Dobrev D. Hyperuricemia: A causal player or a bystander linking inflammatory signaling and atrial fibrillation? International Journal of Cardiology. PMID 27993379 DOI: 10.1016/j.ijcard.2016.12.018 |
0.111 |
|
2016 |
Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D׳Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. Journal of Arrhythmia. 32: 247-78. PMID 27588148 DOI: 10.1016/j.joa.2016.05.002 |
0.111 |
|
2011 |
Wittköpper K, Dobrev D, Eschenhagen T, El-Armouche A. Phosphatase-1 inhibitor-1 in physiological and pathological β-adrenoceptor signalling. Cardiovascular Research. 91: 392-401. PMID 21354993 DOI: 10.1093/cvr/cvr058 |
0.111 |
|
2003 |
Balana B, Dobrev D, Wettwer E, Christ T, Knaut M, Ravens U. Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. Journal of Molecular and Cellular Cardiology. 35: 1399-405. PMID 14654366 DOI: 10.1016/S0022-2828(03)00246-3 |
0.111 |
|
2011 |
Nishida K, Qi XY, Wakili R, Comtois P, Chartier D, Harada M, Iwasaki YK, Romeo P, Maguy A, Dobrev D, Michael G, Talajic M, Nattel S. Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model. Circulation. 123: 137-46. PMID 21200008 DOI: 10.1161/Circulationaha.110.972778 |
0.11 |
|
2002 |
Dobrev D, Wettwer E, Kortner A, Knaut M, Schüler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovascular Research. 54: 397-404. PMID 12062344 DOI: 10.1016/S0008-6363(01)00555-7 |
0.11 |
|
2014 |
Kreusser MM, Lehmann LH, Keranov S, Hoting MO, Oehl U, Kohlhaas M, Reil JC, Neumann K, Schneider MD, Hill JA, Dobrev D, Maack C, Maier LS, Gröne HJ, Katus HA, et al. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy. Circulation. 130: 1262-73. PMID 25124496 DOI: 10.1161/Circulationaha.114.006185 |
0.109 |
|
2008 |
Dobrev D, Wettwer E. Four and a half LIM protein 1: A novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis Cardiovascular Research. 78: 411-412. PMID 18390898 DOI: 10.1093/cvr/cvn092 |
0.109 |
|
2021 |
Dobrev D, Dudley SC. Oxidative stress: a baystander or a causal contributor to atrial remodeling and fibrillation? Cardiovascular Research. PMID 33822005 DOI: 10.1093/cvr/cvab124 |
0.108 |
|
2011 |
Le Quang K, Naud P, Qi XY, Duval F, Shi YF, Gillis MA, Comtois P, Tardif JC, Li D, Levesque PC, Dobrev D, Charpentier F, Nattel S. Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice. Cardiovascular Research. 91: 420-8. PMID 21622683 DOI: 10.1093/Cvr/Cvr082 |
0.107 |
|
2021 |
Vakrilova L, Marinov R, Hitrova-Nikolova S, Dobrev D, Denev M, Lazarov S. Cardiac Myosarcoma in a Newborn Infant-A Case Report and Literature Review. Frontiers in Cardiovascular Medicine. 8: 675202. PMID 34336944 DOI: 10.3389/fcvm.2021.675202 |
0.107 |
|
2021 |
Gawałko M, Dobrev D. Pericardial adipose tissue: An emerging biomarker of atrial fibrillation? International Journal of Cardiology. PMID 33515617 DOI: 10.1016/j.ijcard.2021.01.009 |
0.107 |
|
1974 |
Konstantinov B, Pencev V, Dobrev D, Petrova S. Wedge shaped filter for 'Rokus' telegammatherapeutic device (Bulgarian) Onkologiya. 11: 172-177. |
0.106 |
|
2017 |
Heijman J, Kirchner D, Kunze F, Chrétien EM, Michel-Reher MB, Voigt N, Knaut M, Michel MC, Ravens U, Dobrev D. Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation. International Journal of Cardiology. PMID 29290419 DOI: 10.1016/J.Ijcard.2017.12.050 |
0.106 |
|
2017 |
Neef S, Heijman J, Otte K, Dewenter M, Saadatmand AR, Meyer-Roxlau S, Antos CL, Backs J, Dobrev D, Wagner M, Maier LS, El-Armouche A. Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 28451724 DOI: 10.1007/S00210-017-1376-1 |
0.106 |
|
2020 |
Siebermair J, Lehner S, Sattler SM, Rizas KD, Beckmann BM, Becker A, Schiller J, Metz C, Zacherl M, Vonderlin N, Rassaf T, Dobrev D, Rischpler C, Kääb S, Hacker M, et al. Left-ventricular innervation assessed by I-SPECT/CT is associated with cardiac events in inherited arrhythmia syndromes. International Journal of Cardiology. PMID 32201099 DOI: 10.1016/J.Ijcard.2020.03.013 |
0.105 |
|
2014 |
Greiser M, Kerfant BG, Williams GS, Voigt N, Harks E, Dibb KM, Giese A, Meszaros J, Verheule S, Ravens U, Allessie MA, Gammie JS, van der Velden J, Lederer WJ, Dobrev D, et al. Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. The Journal of Clinical Investigation. 124: 4759-72. PMID 25329692 DOI: 10.1172/Jci70102 |
0.104 |
|
2006 |
El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D. Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation Circulation. 114: 670-680. PMID 16894034 DOI: 10.1161/Circulationaha.106.636845 |
0.104 |
|
1975 |
Mushmov M, Dobrev D. Standard individualized epipharyngeal mold for intracavitary radiotherapy with afterloading (Bulgarian) Onkologiya. 12: 34-38. |
0.104 |
|
2014 |
Chiang DY, Kongchan N, Beavers DL, Alsina KM, Voigt N, Neilson JR, Jakob H, Martin JF, Dobrev D, Wehrens XH, Li N. Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release. Circulation. Arrhythmia and Electrophysiology. 7: 1214-22. PMID 25389315 DOI: 10.1161/Circep.114.001973 |
0.103 |
|
2014 |
Voigt N, Heijman J, Dobrev D. [Cardiovascular pharmacotherapy. Risks and adverse effects]. Herz. 39: 227-38; quiz 239-40. PMID 24691833 DOI: 10.1007/s00059-014-4066-5 |
0.103 |
|
2015 |
Weber S, Meyer-Roxlau S, Wagner M, Dobrev D, El-Armouche A. Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases. Frontiers in Pharmacology. 6: 270. PMID 26617522 DOI: 10.3389/fphar.2015.00270 |
0.102 |
|
2018 |
Morotti S, Ellinwood N, Ni H, Koivumäki JT, Maleckar MM, Heijman J, Dobrev D, Grandi E. Effects of Modulation of Small-Conductance Calcium-Activated Potassium Current on Atrial Electrophysiology and Arrhythmogenesis: A Population-Based Computational Study Biophysical Journal. 114: 473a. DOI: 10.1016/J.Bpj.2017.11.2604 |
0.102 |
|
2007 |
Greiser M, Halaszovich CR, Frechen D, Boknik P, Ravens U, Dobrev D, Lückhoff A, Schotten U. Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn-Schmiedebergs Archives of Pharmacology. 375: 383-392. PMID 17593353 DOI: 10.1007/S00210-007-0174-6 |
0.101 |
|
2013 |
Voigt N, Dobrev D. The biology of human pulmonary veins: Does it help us to better understand AF pathophysiology in patients? Heart Rhythm. 10: 392-393. PMID 23237913 DOI: 10.1016/j.hrthm.2012.12.010 |
0.1 |
|
2011 |
Swaminathan PD, Purohit A, Soni S, Voigt N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, Kutschke W, Yang J, Donahue JK, Weiss RM, Grumbach IM, ... ... Dobrev D, et al. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. The Journal of Clinical Investigation. 121: 3277-88. PMID 21785215 DOI: 10.1172/Jci57833 |
0.098 |
|
2021 |
Ehrlich JR, Dobrev D. Therapy-refractory AF: A clear unmet need for the development of novel antiarrhythmic drugs. International Journal of Cardiology. PMID 33571566 DOI: 10.1016/j.ijcard.2021.02.007 |
0.098 |
|
2009 |
Dobrev D, Teos LY, Lederer WJ. Unique atrial myocyte Ca2+ signaling. Journal of Molecular and Cellular Cardiology. 46: 448-51. PMID 19150353 DOI: 10.1016/j.yjmcc.2008.12.004 |
0.098 |
|
2006 |
Greiser MB, Neuberger H, Haan SD, Harks E, Verheule S, Allessie M, Dobrev D, Ravens U, Schotten U. P4-6: Differential alteration of sarcoplasmic reticulum function in dilated versus fibrillating atria Heart Rhythm. 3. DOI: 10.1016/J.Hrthm.2006.02.661 |
0.097 |
|
2016 |
Heijman J, Schirmer I, Dobrev D. The multiple proarrhythmic roles of cardiac calcium-handling abnormalities: triggered activity, conduction abnormalities, beat-to-beat variability, and adverse remodelling. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 26826138 DOI: 10.1093/europace/euv417 |
0.097 |
|
2021 |
Fogli Iseppe A, Morotti S, Tekook M, Hoffmann D, Edwards AG, Dobrev D, Grandi E. A Modeling Framework for Investigating the Role of Human Atrial Fibroblast Calcium Signaling in Fibrogenesis Biophysical Journal. 120: 53a-54a. DOI: 10.1016/J.BPJ.2020.11.561 |
0.097 |
|
2008 |
Dobrev D, Neycheva T, Mudrov N. Digital lock-in techniques for adaptive power-line interference extraction Physiological Measurement. 29: 803-816. PMID 18560061 DOI: 10.1088/0967-3334/29/7/009 |
0.097 |
|
2016 |
Dobrev D. Unique cardiomyocyte ultrastructure in atria: Role of T tubules in subcellular Ca(2+) signaling and atrial arrhythmogenesis. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 27756707 DOI: 10.1016/j.hrthm.2016.10.013 |
0.096 |
|
1999 |
Dobrev D, Daskalov I. Two-electrode telemetric instrument for infant heart rate and apnea monitoring Medical Engineering and Physics. 20: 729-734. PMID 10223641 DOI: 10.1016/S1350-4533(98)00091-5 |
0.096 |
|
2014 |
Dobrev D, Wehrens XH. Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease. Circulation Research. 114: 1311-9; discussion 1. PMID 24723656 DOI: 10.1161/CIRCRESAHA.114.300568 |
0.096 |
|
2005 |
Dobrev D, Friedrich A, Knuschke D, Christ T, Wettwer E, Knaut M, Ravens U. The 825T-allele of the GNB3 gene is associated with higher basal inward rectifier current in human chronic atrial fibrillation Heart Rhythm. 2. DOI: 10.1016/J.Hrthm.2005.02.052 |
0.095 |
|
2014 |
Li N, Chiang DY, Voigt N, Martin JF, Dobrev D, Wehrens XH. GW25-e5168 Impaired Post-Transcriptional Regulation of RyR2 by microRNA-106b-25 Cluster Promotes Atrial Fibrillation Journal of the American College of Cardiology. 64: C59. DOI: 10.1016/J.JACC.2014.06.284 |
0.095 |
|
2021 |
Gawałko M, Dobrev D. Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited. International Journal of Cardiology. PMID 33744347 DOI: 10.1016/j.ijcard.2021.03.022 |
0.094 |
|
2016 |
Goette A, Nattel S, Kalman J, Aguinaga L, Cabrera JA, Corradi D, Dobrev D, Hatem SN, Lip GY, Hindricks G, Ho SY, Wagoner DV, Chugh SS, Gonzalez M, Helm R, et al. TEMPORARY REMOVAL: Atrial Cardiomyopathies: Definition, Characterization and Clinical Implication. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 27320515 DOI: 10.1016/J.Hrthm.2016.05.028 |
0.094 |
|
2013 |
Levay M, Krobert KA, Wittig K, Voigt N, Bermudez M, Wolber G, Dobrev D, Levy FO, Wieland T. NSC23766, a widely used inhibitor of Rac1 activation, additionally acts as a competitive antagonist at muscarinic acetylcholine receptors. The Journal of Pharmacology and Experimental Therapeutics. 347: 69-79. PMID 23887096 DOI: 10.1124/jpet.113.207266 |
0.094 |
|
2020 |
Gawałko M, Jespersen T, Dobrev D, Linz D. The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation? International Journal of Cardiology. Heart & Vasculature. 29: 100581. PMID 32885798 DOI: 10.1016/J.Ijcha.2020.100581 |
0.093 |
|
2016 |
Stathopoulou K, Wittig I, Heidler J, Piasecki A, Richter F, Diering S, van der Velden J, Buck F, Donzelli S, Schröder E, Wijnker PJ, Voigt N, Dobrev D, Sadayappan S, Eschenhagen T, et al. S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26839380 DOI: 10.1096/fj.201500048 |
0.093 |
|
2018 |
Joos JP, Saadatmand AR, Schnabel C, Viktorinová I, Brand T, Kramer M, Nattel S, Dobrev D, Tomancak P, Backs J, Kleinbongard P, Heusch G, Lorenz K, Koch E, Weber S, et al. Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila. Scientific Reports. 8: 2940. PMID 29440697 DOI: 10.1038/S41598-018-21372-3 |
0.092 |
|
2020 |
Tomasovic A, Brand T, Schanbacher C, Kramer S, Hümmert MW, Godoy P, Schmidt-Heck W, Nordbeck P, Ludwig J, Homann S, Wiegering A, Shaykhutdinov T, Kratz C, Knüchel R, Müller-Hermelink HK, ... ... Dobrev D, et al. Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects. Nature Communications. 11: 1733. PMID 32265441 DOI: 10.1038/s41467-020-15505-4 |
0.092 |
|
2019 |
Linz D, Baumert M, Desteghe L, Kadhim K, Vernooy K, Kalman JM, Dobrev D, Arzt M, Sastry M, Crijns HJGM, Schotten U, Cowie MR, McEvoy RD, Heidbuchel H, Hendriks J, et al. Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring. International Journal of Cardiology. Heart & Vasculature. 24: 100424. PMID 31763438 DOI: 10.1016/j.ijcha.2019.100424 |
0.091 |
|
2019 |
Belau F, Metzner K, Christ T, Ravens U, Schaefer M, Künzel S, Li W, Wettwer E, Dobrev D, El-Armouche A, Kämmerer S. DPP10 is a new regulator of Nav1.5 channels in human heart. International Journal of Cardiology. PMID 30638748 DOI: 10.1016/J.Ijcard.2018.12.072 |
0.09 |
|
2018 |
Campbell H, Ni L, Reynolds J, Alsina K, Veleva T, Abu-Taha I, Quick A, Donoviel Z, Li N, Dobrev D, Wehrens X. Abstract 252: Downregulated Striated Muscle Preferentially Expressed Protein Kinase Enhances Susceptibility to Post-Operative Atrial Fibrillation Circulation Research. 123. DOI: 10.1161/res.123.suppl_1.252 |
0.09 |
|
2013 |
Le Quang K, Benito B, Naud P, Qi XY, Shi YF, Tardif JC, Gillis MA, Dobrev D, Charpentier F, Nattel S. T-type calcium current contributes to escape automaticity and governs the occurrence of lethal arrhythmias after atrioventricular block in mice. Circulation. Arrhythmia and Electrophysiology. 6: 799-808. PMID 23884198 DOI: 10.1161/Circep.113.000407 |
0.09 |
|
2019 |
Linz D, Dobrev D. Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor? International Journal of Cardiology. Heart & Vasculature. 23: 100360. PMID 31016225 DOI: 10.1016/j.ijcha.2019.100360 |
0.09 |
|
2014 |
Stathopoulou K, Boontje N, Buck F, Schroeder E, Voigt N, Dobrev D, Van Der Velden J, Eschenhagen T, Carrier L, Cuello F. P678S-glutathiolation of cMyBP-C reduces its phosphorylation and contributes to impairment of cardiac myocyte contractile function Cardiovascular Research. 103: S123.3-S124. DOI: 10.1093/CVR/CVU098.102 |
0.089 |
|
1993 |
Pavlova E, Dobrev D. Changes in the heart rhythm studied by the PWC170 test following physical loading Eksperimentalna Medicina I Morfologiya. 31: 1-6. PMID 8258311 |
0.089 |
|
2012 |
Respress JL, Van Oort RJ, Li N, Rolim N, Dixit SS, Dealmeida A, Voigt N, Lawrence WS, Skapura DG, Skårdal K, Wisløff U, Wieland T, Ai X, Pogwizd SM, Dobrev D, et al. Role of RyR2 phosphorylation at S2814 during heart failure progression Circulation Research. 110: 1474-1483. PMID 22511749 DOI: 10.1161/CIRCRESAHA.112.268094 |
0.089 |
|
2013 |
Dobrev D, Voigt N, Nattel S. Cholinergic and Constitutive Regulation of Atrial Potassium Channel Cardiac Electrophysiology: From Cell to Bedside: Sixth Edition. 383-391. DOI: 10.1016/B978-1-4557-2856-5.00038-8 |
0.088 |
|
2005 |
Stanchev NK, Dobrev DM. Transmitted-reference quaternary phase modulation scheme for impulse radio Eurocon 2005 - the International Conference On Computer as a Tool. 1807-1809. |
0.088 |
|
2021 |
Linz D, Linz B, Homberg M, Bouman E, Dobrev D, Hendriks JM, Simons SO. Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation. International Journal of Cardiology. Heart & Vasculature. 33: 100783. PMID 34095446 DOI: 10.1016/j.ijcha.2021.100783 |
0.088 |
|
2005 |
Christ T, Adolph E, Schindelhauer S, Wettwer E, Dobrev D, Wallukat G, Ravens U. Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes. Basic & Clinical Pharmacology & Toxicology. 96: 445-452. DOI: 10.1111/J.1742-7843.2005.Pto_96607.X |
0.088 |
|
2007 |
El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh Y, Nattel S, Dobrev D, Eschenhagen T, Carrier L. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure Journal of Molecular and Cellular Cardiology. 43: 223-229. PMID 17560599 DOI: 10.1016/J.Yjmcc.2007.05.003 |
0.088 |
|
2000 |
Himmel HM, Meyer Zu Heringdorf D, Graf E, Dobrev D, Kortner A, Schüler S, Jakobs KH, Ravens U. Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. Molecular Pharmacology. 58: 449-54. PMID 10908314 DOI: 10.1124/Mol.58.2.449 |
0.088 |
|
2018 |
Sutanto H, Dobrev D, Grandi E, Volders PG, Heijman J. Calcium-Dependent Regulation of Potassium Channels in Cardiac Electrophysiology: A Computational Study Biophysical Journal. 114: 473a. DOI: 10.1016/J.BPJ.2017.11.2603 |
0.088 |
|
2016 |
Abu-Taha IH, Heijman J, Hippe HJ, Wolf NM, El-Armouche A, Nikolaev VO, Schäfer M, Würtz C, Neef S, Voigt N, Baczkó I, Varró A, Müller M, Meder B, Katus HA, ... ... Dobrev D, et al. Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure. Circulation. PMID 27927712 DOI: 10.1161/Circulationaha.116.022852 |
0.088 |
|
2006 |
Nedelchev M, Dobrev D. Low sensitivity symmetrical response microwave filters Microelectronics Journal. 37: 546-553. DOI: 10.1016/j.mejo.2005.08.002 |
0.087 |
|
2020 |
Fender AC, Dobrev D. The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation. International Journal of Cardiology. PMID 33011170 DOI: 10.1016/j.ijcard.2020.09.067 |
0.087 |
|
2012 |
Zhou X, Dobrev D. Voltage-gated Na⁺ channels: novel players in fibroblast-to-myofibroblast transition with a potential role in atrial arrhythmogenesis? The Journal of Physiology. 590: 4975. PMID 23082023 DOI: 10.1113/jphysiol.2012.241455 |
0.087 |
|
2000 |
Dobrev D, Wettwer E, Himmel HM, Kortner A, Kuhlisch E, Schüler S, Siffert W, Ravens U. G-Protein β3-Subunit 825T Allele Is Associated With Enhanced Human Atrial Inward Rectifier Potassium Currents Circulation. 102: 692-697. PMID 10931811 DOI: 10.1161/01.Cir.102.6.692 |
0.087 |
|
2014 |
Harada M, Luo X, Murohara T, Yang B, Dobrev D, Nattel S. MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential. Circulation Research. 114: 689-705. PMID 24526675 DOI: 10.1161/Circresaha.114.301798 |
0.086 |
|
2005 |
Frey UH, Nückel H, Dobrev D, Manthey I, Sandalcioglu IE, Eisenhardt A, Worm K, Hauner H, Siffert W. Quantification of G protein Gaalphas subunit splice variants in different human tissues and cells using pyrosequencing. Gene Expression. 12: 69-81. PMID 15892449 DOI: 10.3727/000000005783992124 |
0.086 |
|
2021 |
Linz D, Linz B, Dobrev D, Baumert M, Hendriks JM, Pepin JL, Jespersen T. Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge. International Journal of Cardiology. Heart & Vasculature. 35: 100843. PMID 34377764 DOI: 10.1016/j.ijcha.2021.100843 |
0.086 |
|
1997 |
Dobrev D, Kornovski B, Manevska B. Mechanisms underlying the development of gastroesophageal reflux disease Biomedical Reviews. 8: 101-109. |
0.086 |
|
2006 |
Dobrev D, Jordanova L. Noise and distortions limitations in the design of HFC CATV systems Optical Fiber Technology. 12: 196-204. DOI: 10.1016/j.yofte.2005.08.001 |
0.085 |
|
1998 |
Grossmann M, Dobrev D, Kirch W. Amiodarone causes endothelium-dependent vasodilation in human hand veins in vivo Clinical Pharmacology and Therapeutics. 64: 302-311. PMID 9757154 DOI: 10.1016/S0009-9236(98)90179-5 |
0.085 |
|
2019 |
Linz D, Ammirati E, Dan GA, Heijman J, Dobrev D. Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction. International Journal of Cardiology. Heart & Vasculature. 25: 100443. PMID 31890863 DOI: 10.1016/j.ijcha.2019.100443 |
0.085 |
|
2003 |
Dobrev D. Transcription factors for ion channels: Active or passive players in cardiac remodeling? Cardiovascular Research. 60: 226-227. PMID 14613850 DOI: 10.1016/j.cardiores.2003.09.008 |
0.085 |
|
2014 |
Chen Y, Wakili R, Xiao J, Wu CT, Luo X, Clauss S, Dawson K, Qi X, Naud P, Shi YF, Tardif JC, Kääb S, Dobrev D, Nattel S. Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling. Journal of Molecular and Cellular Cardiology. 77: 113-24. PMID 25315712 DOI: 10.1016/J.Yjmcc.2014.10.001 |
0.084 |
|
2001 |
Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U. Autoantibodies Against the β1adrenoceptor from Patients with Dilated Cardiomyopathy Prolong Action Potential Duration and Enhance Contractility in Isolated Cardiomyocytes Journal of Molecular and Cellular Cardiology. 33: 1515-1525. PMID 11448139 DOI: 10.1006/Jmcc.2001.1414 |
0.084 |
|
2011 |
Boontje NM, Merkus D, Zaremba R, Versteilen A, de Waard MC, Mearini G, de Beer VJ, Carrier L, Walker LA, Niessen HWM, Dobrev D, Stienen GJM, Duncker DJ, Van der Velden J. Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardium Journal of Molecular and Cellular Cardiology. 50: 487-499. PMID 21156182 DOI: 10.1016/j.yjmcc.2010.12.002 |
0.084 |
|
2019 |
Wakili R, Riesinger L, Fender AC, Dobrev D. Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease? International Journal of Cardiology. Heart & Vasculature. 23: 100369. PMID 31111088 DOI: 10.1016/j.ijcha.2019.100369 |
0.083 |
|
2007 |
Voigt N, Friedrich A, Bock M, Wettwer E, Christ T, Knaut M, Strasser RH, Ravens U, Dobrev D. Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovascular Research. 74: 426-437. PMID 17362895 DOI: 10.1016/J.Cardiores.2007.02.009 |
0.083 |
|
2006 |
El-Armouche A, Bednorz A, Pamminger T, Ditz D, Didié M, Dobrev D, Eschenhagen T. Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. Biochemical and Biophysical Research Communications. 346: 700-6. PMID 16774736 DOI: 10.1016/J.BBRC.2006.05.182 |
0.081 |
|
2008 |
Dobrev DP, Neycheva T, Mudrov N. Bootstrapped two-electrode biosignal amplifier. Medical & Biological Engineering & Computing. 46: 613-9. PMID 18266016 DOI: 10.1007/s11517-008-0312-4 |
0.08 |
|
2002 |
Christ T, Dobrev D, Wallukat G, Schüler S, Ravens U. Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies. Methods and Findings in Experimental and Clinical Pharmacology. 23: 141-4. PMID 11523313 DOI: 10.1358/MF.2001.23.3.627947 |
0.079 |
|
2007 |
Eichhorn B, Dobrev D. Vascular large conductance calcium-activated potassium channels: Functional role and therapeutic potential Naunyn-Schmiedeberg's Archives of Pharmacology. 376: 145-155. PMID 17932654 DOI: 10.1007/s00210-007-0193-3 |
0.079 |
|
2021 |
Fender AC, Dobrev D. Potential antiarrhythmic actions of anticoagulants: Do they exist and can they be clinically unmasked? International Journal of Cardiology. PMID 33516836 DOI: 10.1016/j.ijcard.2021.01.010 |
0.077 |
|
2009 |
Dobrev D, Kolev K. State and development of the undeveloped rural regions in Bulgaria: The example of dulgopol municipality Ikonomicheski Izsledvania. 18. |
0.077 |
|
2003 |
Ravens U, Dobrev D. Cardiac sympathetic innervation and control of potassium channel function Journal of Molecular and Cellular Cardiology. 35: 137-139. PMID 12606253 DOI: 10.1016/S0022-2828(02)00307-3 |
0.077 |
|
2019 |
Barefield DY, McNamara JW, Lynch TL, Kuster DWD, Govindan S, Haar L, Wang Y, Taylor EN, Lorenz JN, Nieman ML, Zhu G, Luther PK, Varró A, Dobrev D, Ai X, et al. Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury. Journal of Molecular and Cellular Cardiology. PMID 30862451 DOI: 10.1016/j.yjmcc.2019.03.006 |
0.076 |
|
2003 |
Graf EM, Dobrev D, Heubach JF, Bock M, Ravens U. 901 Post‐operative atrial fibrillation after coronary artery bypass grafting is predicted by enhanced mRNA levels of the L‐type Ca2+ channel alpha1C subunit European Journal of Heart Failure Supplements. 2: 187-187. DOI: 10.1016/S1567-4215(03)90565-0 |
0.075 |
|
2017 |
Heijman J, Dobrev D. Ion channels as part of macromolecular multiprotein complexes : Clinical significance. Herzschrittmachertherapie & Elektrophysiologie. PMID 29214349 DOI: 10.1007/s00399-017-0542-y |
0.074 |
|
2002 |
Dobrev D. Use PSpice for behavioral modeling of VCOs Edn. 47: 102-104. |
0.073 |
|
2020 |
Fender AC, Kleeschulte S, Stolte S, Leineweber K, Kamler M, Bode J, Li N, Dobrev D. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart. Basic Research in Cardiology. 115: 10. PMID 31912235 DOI: 10.1007/s00395-019-0771-9 |
0.073 |
|
2020 |
Linz D, Dobrev D. Sleep apnea and atrial fibrillation: Update 2020. International Journal of Cardiology. Heart & Vasculature. 31: 100681. PMID 33304991 DOI: 10.1016/j.ijcha.2020.100681 |
0.073 |
|
1991 |
Dobrev D, Kornovski B, Shterev S. Manometry of the upper gastrointestinal tract in esophageal reflux disease Internal Diseases. 30: 68-72. PMID 1891905 |
0.073 |
|
2003 |
Dobrev D, Ravens U. Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum European Journal of Pharmacology. 461: 105-111. PMID 12586205 DOI: 10.1016/S0014-2999(03)01319-0 |
0.072 |
|
2018 |
Dobrev D, Fender AC, Wehrens XHT. Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter? Cardiovascular Research. PMID 29982290 DOI: 10.1093/cvr/cvy175 |
0.072 |
|
2013 |
Mehel H, Emons J, Vettel C, Wittköpper K, Seppelt D, Dewenter M, Lutz S, Sossalla S, Maier LS, Lechêne P, Leroy J, Lefebvre F, Varin A, Eschenhagen T, Nattel S, ... Dobrev D, et al. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. Journal of the American College of Cardiology. 62: 1596-606. PMID 23810893 DOI: 10.1016/J.Jacc.2013.05.057 |
0.072 |
|
2004 |
Dobrev D. Two-electrode low supply voltage electrocardiogram signal amplifier Medical and Biological Engineering and Computing. 42: 272-276. PMID 15125160 DOI: 10.1007/BF02344642 |
0.072 |
|
1998 |
Vetter J, Scholz R, Dobrev D, Nistor L. HREM investigation of latent tracks in GeS and mica induced by high energy ions Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions With Materials and Atoms. 141: 747-752. |
0.071 |
|
1975 |
Stefanova D, Dobrev D, Djarova T. Correlative dependence between oxygen consumption, heart rate, blood lactate and acid-base equilibrium at interval loading in laboratory conditions Agressologie. 16: 25-30. PMID 1232832 |
0.071 |
|
2018 |
Ammirati E, Dobrev D. Conventional Troponin-I versus high-sensitivity troponin-T: Performance and incremental prognostic value in non-ST-elevation acute myocardial infarction patients with negative CK-MB based on a real-world multicenter cohort. International Journal of Cardiology. Heart & Vasculature. 20: 38-39. PMID 30094334 DOI: 10.1016/j.ijcha.2018.07.002 |
0.069 |
|
2017 |
Abu-Taha IH, Heijman J, Feng Y, Vettel C, Dobrev D, Wieland T. Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 29035382 DOI: 10.1038/labinvest.2017.103 |
0.069 |
|
2003 |
Dobrev D. High-CMRR instrumentation amp works with low supply voltages Edn. 48: 88-90. |
0.069 |
|
2005 |
Stanchev NK, Dobrev D. Influence of the delay line accuracy on the spectrum of impulse radio with transmitted-reference quaternary phase modulation Eurocon 2005 - the International Conference On Computer as a Tool. 1810-1813. |
0.068 |
|
2002 |
Dobrev D. Two-electrode non-differential biopotential amplifier Medical and Biological Engineering and Computing. 40: 546-549. PMID 12452415 |
0.068 |
|
2000 |
Himmel HM, Dobrev D, Grossmann M, Ravens U. N-desethylamiodarone modulates intracellular calcium concentration in endothelial cells Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 489-496. PMID 11138840 DOI: 10.1007/S002100000301 |
0.068 |
|
2005 |
Mueller MP, Christ T, Dobrev D, Nitsche I, Stehr SN, Ravens U, Koch T. Teaching antiarrhythmic therapy and ECG in simulator-based interdisciplinary undergraduate medical education Bja: British Journal of Anaesthesia. 95: 300-304. PMID 15964889 DOI: 10.1093/Bja/Aei174 |
0.068 |
|
2021 |
Garnier A, Bork NI, Jacquet E, Zipfel S, Muñoz-Guijosa C, Baczkó I, Reichenspurner H, Donzeau-Gouge P, Maier LS, Dobrev D, Girdauskas E, Nikolaev VO, Fischmeister R, Molina CE. Mapping genetic changes in the cAMP-signaling cascade in human atria. Journal of Molecular and Cellular Cardiology. PMID 33631188 DOI: 10.1016/j.yjmcc.2021.02.006 |
0.068 |
|
1980 |
Dobrev D, Manolov D, Turkolev N. Carbohydrate tolerance and serum insulin in hypertension Internal Diseases. 19: 67-72. PMID 7010788 |
0.067 |
|
2008 |
El-Armouche A, Wittköpper K, Degenhardt F, Weinberger F, Didié M, Melnychenko I, Grimm M, Peeck M, Zimmermann WH, Unsöld B, Hasenfuss G, Dobrev D, Eschenhagen T. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovascular Research. 80: 396-406. PMID 18689792 DOI: 10.1093/cvr/cvn208 |
0.067 |
|
2005 |
Dobrev D, Neycheva T, Mudrov N. Simple two-electrode biosignal amplifier Medical and Biological Engineering and Computing. 43: 725-730. PMID 16594298 DOI: 10.1007/BF02430949 |
0.066 |
|
2021 |
Linz D, Dobrev D. A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic. International Journal of Cardiology. Heart & Vasculature. 33: 100749. PMID 33748403 DOI: 10.1016/j.ijcha.2021.100749 |
0.066 |
|
2015 |
Zhou XB, Feng YX, Sun Q, Lukowski R, Qiu Y, Spiger K, Li Z, Ruth P, Korth M, Skolnik EY, Borggrefe M, Dobrev D, Wieland T. Nucleoside Diphosphate Kinase B-Activated Intermediate Conductance Potassium Channels Are Critical for Neointima Formation in Mouse Carotid Arteries. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26088577 DOI: 10.1161/ATVBAHA.115.305881 |
0.065 |
|
2015 |
Heijman J, Heusch G, Dobrev D. Tools to Keep the Clock Ticking: Molecular Approaches to Treat Sinus Node Dysfunction. Cardiology. 132: 45-8. PMID 26044937 DOI: 10.1159/000430783 |
0.065 |
|
2012 |
Zhou X, Wulfsen I, Korth M, McClafferty H, Lukowski R, Shipston MJ, Ruth P, Dobrev D, Wieland T. Palmitoylation and membrane association of the stress axis regulated insert (STREX) controls BK channel regulation by protein kinase C. The Journal of Biological Chemistry. 287: 32161-71. PMID 22843729 DOI: 10.1074/Jbc.M112.386359 |
0.065 |
|
1975 |
Dobrev D, Pavlov D, Stoilov L. Insulin hypoglycemia, a functional test of the state of the hypothalamo-hypophyseo-adrenal system in obesity Internal Diseases. 14: 73-78. PMID 1224611 |
0.064 |
|
1998 |
Dobrev D, Vetter J, Neumann R. Growth of potassium iodide single-crystals using ion track membranes as templates Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions With Materials and Atoms. 146: 513-517. |
0.064 |
|
2003 |
Schindler C, Grossmann M, Dobrev D, Francke K, Ravens U, Kirch W. Reproducibility of dorsal hand vein responses to phenylephrine and prostaglandin F2 alpha using the dorsal hand vein compliance method. Journal of Clinical Pharmacology. 43: 228-36. PMID 12638390 DOI: 10.1177/0091270002251004 |
0.062 |
|
1999 |
Dobrev D, Milde AS, Andreas K, Ravens U. The effects of verapamil and diltiazem on N‐, P‐ and Q‐type calcium channels mediating dopamine release in rat striatum British Journal of Pharmacology. 127: 576-582. PMID 10385261 DOI: 10.1038/Sj.Bjp.0702574 |
0.062 |
|
2004 |
Schindler C, Dobrev D, Grossmann M, Francke K, Pittrow D, Kirch W. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans. Clinical Pharmacology and Therapeutics. 75: 49-59. PMID 14749691 DOI: 10.1016/j.clpt.2003.09.009 |
0.062 |
|
2018 |
Tsuji Y, Dobrev D. Prognostic impact of electrical storm in patients with implantable cardioverter defibrillators: Mechanistic and therapeutic considerations to reduce the risk of death. International Journal of Cardiology. 255: 101-102. PMID 29425546 DOI: 10.1016/j.ijcard.2017.12.085 |
0.062 |
|
2001 |
Grossmann M, Dobrev D, Siffert W, Kirch W. Heterogeneity in hand veins responses to acetylcholine is not associated with polymorphisms in the G-protein β3subunit (C825T) and endothelial nitric oxide synthase (G894t) genes but with serum low density lipoprotein cholesterol Pharmacogenetics. 11: 307-316. PMID 11434508 DOI: 10.1097/00008571-200106000-00005 |
0.062 |
|
2003 |
Dobrev D. Two op amps provide averaged absolute value Edn. 48: 98. |
0.062 |
|
2019 |
Ciuculete DC, Dobrev D, Dan GA. Prognostic value of biomarkers of impaired metabolism in heart failure patients with reduced ejection fraction. International Journal of Cardiology. Heart & Vasculature. 25: 100441. PMID 31890861 DOI: 10.1016/j.ijcha.2019.100441 |
0.061 |
|
2001 |
Grossmann M, Dobrev D, Himmel HM, Ravens U, Kirch W. Ascorbic Acid–Induced Modulation of Venous Tone in Humans Hypertension. 37: 949-954. PMID 11244023 DOI: 10.1161/01.Hyp.37.3.949 |
0.061 |
|
1999 |
Dobrev D, Vetter J, Angert N, Neumann R. Electrochemical growth of copper single crystals in pores of polymer ion-track membranes Applied Physics a: Materials Science and Processing. 69: 233-237. DOI: 10.1007/s003390050995 |
0.06 |
|
1999 |
Dobrev D, Vetter J, Angert N. Electrochemical preparation of metal microstructures on large areas of etched ion track membranes Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions With Materials and Atoms. 149: 207-212. |
0.058 |
|
2021 |
Fender AC, Dobrev D. Soluble fibrin monomer complex as a candidate sentinel for adverse events in patients with heart failure. International Journal of Cardiology. Heart & Vasculature. 32: 100712. PMID 33490365 DOI: 10.1016/j.ijcha.2020.100712 |
0.058 |
|
1998 |
Dobrev D, Milde AS, Andreas K, Ravens U. Voltage-activated calcium channels involved in veratridine-evoked [3H]dopamine release in rat striatal slices Neuropharmacology. 37: 973-982. PMID 9833626 DOI: 10.1016/S0028-3908(98)00103-8 |
0.056 |
|
2003 |
Dobrev D. Amplifier and current source emulate instrumentation amplifier Edn. 48: 110. |
0.054 |
|
1991 |
Kostadinov L, Dobrev D. A low working pressure magnetron sputtering source Vacuum. 42: 35-37. DOI: 10.1016/0042-207X(91)90073-R |
0.054 |
|
2020 |
Fender AC, Dobrev D. Pleiotropic actions of ticagrelor versus clopidogrel - Do molecular differences translate into superior clinical efficacy after myocardial infarction? International Journal of Cardiology. Heart & Vasculature. 27: 100508. PMID 32310244 DOI: 10.1016/j.ijcha.2020.100508 |
0.053 |
|
2000 |
Grossmann M, Dobrev D, Himmel HM, Kirch W. Local venous response to N-desethylamiodarone in humans. Clinical Pharmacology and Therapeutics. 67: 22-31. PMID 10668850 DOI: 10.1067/mcp.2000.103822 |
0.053 |
|
2016 |
Stoulil J, Dobrev D. Microbial corrosion of metallic materials in a deep nuclear-waste repository Koroze a Ochrana Materialu. 60: 59-67. DOI: 10.1515/kom-2016-0010 |
0.053 |
|
1974 |
Mitrov G, Dobrev D, Musmov M. Lead screens for the protection of the lower jaw and upper lip from irradiation in intratissue gamma therapy of mandibular cancer (Bulgarian) Onkologiya. 11: 136-140. |
0.053 |
|
2002 |
Ravens U, Nitsche I, Haag C, Dobrev D. What is a good tutorial from the student's point of view? Evaluation of tutorials in a newly established PBL block course "Basics of Drug Therapy", Naunyn-Schmiedeberg's Archives of Pharmacology. 366: 69-76. PMID 12107636 DOI: 10.1007/S00210-002-0569-3 |
0.052 |
|
2013 |
Heijman J, Dobrev D. KCNQ1 autoantibodies: another way to regulate IKs. Cardiovascular Research. 98: 329-31. PMID 23615563 DOI: 10.1093/cvr/cvt099 |
0.052 |
|
1994 |
Pavlovska A, Dobrev D, Bauer E. Roughening transition of tetragonal metals: an initial growth shape study Surface Science. 314: 331-340. DOI: 10.1016/0039-6028(94)90235-6 |
0.052 |
|
2021 |
Fender AC, Dobrev D. Nitric oxide as a fragile switch between cardioprotection and cardiac injury. International Journal of Cardiology. 343: 102-103. PMID 34499973 DOI: 10.1016/j.ijcard.2021.09.001 |
0.052 |
|
2009 |
Petkova NB, Dobrev D. Alternative and ecological fuels. a review Oxidation Communications. 32: 425-440. |
0.052 |
|
2000 |
Dobrev D, Vetter J, Angert N, Neumann R. Periodic reverse current electrodeposition of gold in an ultrasonic field using ion-track membranes as templates: Growth of gold single-crystals Electrochimica Acta. 45: 3117-3125. DOI: 10.1016/S0013-4686(00)00478-3 |
0.051 |
|
2005 |
Dobrev D, Baur D, Neumann R. Crystallization of lysozyme in pores of etched heavy-ion tracks Applied Physics a: Materials Science and Processing. 80: 451-456. DOI: 10.1007/s00339-004-3078-z |
0.051 |
|
1997 |
Dobrev D, Andreas K. Modulation of potassium-evoked [3H]dopamine release from rat striatal slices by voltage-activated calcium channel ligands: Effects of ω-conotoxin- MVIIC Neurochemical Research. 22: 1085-1093. PMID 9251097 DOI: 10.1023/A:1027305016440 |
0.051 |
|
1988 |
Grantscharova E, Dobrev D. Formation of texture in vacuum-condensed tin on glass Thin Solid Films. 161: 213-221. DOI: 10.1016/0040-6090(88)90253-2 |
0.05 |
|
1973 |
Sejretova E, Dobrev D, Pesev N. Thyroid gland functional radioisotope diagnosis in patients with obesity (Bulgarian) Vatrechni Bolesti. 12: 60-64. PMID 4770077 |
0.05 |
|
2009 |
Dobrev D. Editorial: Ion channel portrait of the human sinus nodeuseful for a better understanding of sinus node function and dysfunction in humans? Circulation. 119: 1556-1558. PMID 19332478 DOI: 10.1161/CIRCULATIONAHA.108.836866 |
0.049 |
|
2011 |
Bugert P, Elmas E, Stach K, Weiss C, Kälsch T, Dobrev D, Borggrefe M. No evidence for an association between the rs2824292 variant at chromosome 21q21 and ventricular fibrillation during acute myocardial infarction in a German population. Clinical Chemistry and Laboratory Medicine. 49: 1237-9. PMID 21574885 DOI: 10.1515/CCLM.2011.190 |
0.049 |
|
1975 |
Dobrev DG, Ilkov A. Carbohydrate tolerance, serum insulin and triglycerides in coronary disease Internal Diseases. 14: 11-22. PMID 1224616 |
0.048 |
|
2002 |
Dobrev D, Daskalov I. Two-electrode biopotential amplifier with current-driven inputs Medical and Biological Engineering and Computing. 40: 122-127. PMID 11954699 |
0.048 |
|
1990 |
Terzieva T, Krǔstev I, Dobrev D, Petrova V. Changes in the high-density lipoprotein level in patients with diabetes mellitus type II Internal Diseases. 29: 89-92. PMID 2284807 |
0.047 |
|
1973 |
Mitrov G, Pencev V, Konstantinov B, Dobrev D. Partition field irradiation technique in the 'Rocus' telegammatherapy apparatus (Bulgarian) Rentgenologiya I Radiologiya. 12: 187-190. |
0.045 |
|
1993 |
Pavlovska A, Dobrev D, Bauer E. Surface melting versus surface non-melting: an equilibrium shape study Surface Science. 286: 176-181. DOI: 10.1016/0039-6028(93)90567-4 |
0.045 |
|
2003 |
Dobrev D, Neumann R, Angert N, Vetter J. Formation of metal membranes by direct duplication of etched ion-track templates Applied Physics a: Materials Science and Processing. 76: 787-790. DOI: 10.1007/s00339-002-1494-5 |
0.045 |
|
1990 |
Georgiev N, Dobrev D. Epitaxy of silver films deposited onto NaCl(100) substrates during ion bombardment Thin Solid Films. 189: 81-89. DOI: 10.1016/0040-6090(90)90029-D |
0.045 |
|
2018 |
Yamazaki M, Tsuji Y, Niwa R, Tomii N, Arafune T, Honjo H, Dobrev D, Nattel S, Kodama I, Sakuma I, Makita N. Role of Late Sodium Current in Experimental Torsade de Pointes Journal of Electrocardiology. 51: 1175-1176. DOI: 10.1016/J.Jelectrocard.2018.10.052 |
0.045 |
|
1979 |
Stoicev D, Dobrev D. Dose distribution in the pelvis in intracavitary curietherapy of patients with cancer of uterine cervix Rentgenologiya I Radiologiya. 18: 94-97. |
0.044 |
|
1971 |
Dobrev D. Evaluation of orthostatic reaction by means of an orthostatic coefficient Agressologie. 12. PMID 5290178 |
0.044 |
|
2014 |
Heijman J, Dobrev D. Rat engineered heart tissue: a novel tool in the safety pharmacology toolkit? Basic Research in Cardiology. 109: 437. PMID 25209141 DOI: 10.1007/s00395-014-0437-6 |
0.044 |
|
1978 |
Mitrov G, Todorov I, Velickov L, Dobrev D. Clinico-roentgenologic studies on radiation pneumonitis following postoperative telegammatherapy of breast cancer Rentgenologiya I Radiologiya. 17: 122-129. |
0.044 |
|
1998 |
Michailov E, Georgiev N, Dobrev D. Effects of substrate temperature and ion irradiation on the formation and structure of Co films on NaCl(100) Vacuum. 51: 205-209. |
0.044 |
|
1977 |
Todorov I, Konstantinov B, Mitrov G, Dobrev D. Postoperative telegammatherapy of breast cancer (dosimetric studies) Rentgenologiya I Radiologiya. 16: 144-150. |
0.043 |
|
2014 |
Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, ... ... Dobrev D, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 46: 517-92. PMID 25173601 DOI: 10.1093/Ejcts/Ezu366 |
0.043 |
|
1978 |
Grigorov G, Dobrev D, Sartmadzieva S, Todorov I. Localized 'pseudofracture' type of pathologic reconstruction of costal bone structure following surgical and radiation treatment of breast cancer Rentgenologiya I Radiologiya. 17: 57-62. |
0.043 |
|
1979 |
Dobrev D, Lazarov G. Diabetic heart Internal Diseases. 18: 1-8. PMID 380167 |
0.043 |
|
2003 |
Schindler C, Grossmann M, Dobrev D, Hultsch E, Kirch W. L-type calcium channels mediate the vascular effects of potassium chloride in human hand veins in vivo Clinical Pharmacology & Therapeutics. 73: P68-P68. DOI: 10.1016/S0009-9236(03)90608-4 |
0.042 |
|
1975 |
Elenkova A, Dobrev D. Changes in the hemodynamics in diabetes mellitus Internal Diseases. 14: 39-48. PMID 1226719 |
0.041 |
|
1988 |
Tzaneva D, Stoyanchev R, Dobrev D. Structural properties of coatings prepared by flash evaporation and magnetron sputtering of Cu-15% Sn and Cu-20% Sn alloys Vacuum. 38: 1019-1024. DOI: 10.1016/0042-207X(88)90567-2 |
0.041 |
|
2002 |
Ravens U, Dobrev D, Haag C. Problem-based learning: A new pathway to competence? [3] Trends in Pharmacological Sciences. 23. PMID 11931987 DOI: 10.1016/S0165-6147(00)01938-6 |
0.041 |
|
1964 |
POPCHRISTOV P, BOTEV S, DOBREV D. STUDIES ON THE DYNAMICS OF THE CLASSIFICATION AND BIOLOGICAL PROPERTIES OF BACTERIAL FLORA OF THE SKIN IN STAPHYLOGENIC PYODERMAS Der Hautarzt; Zeitschrift FüR Dermatologie, Venerologie, Und Verwandte Gebiete. 15: 156-161. PMID 14217831 |
0.04 |
|
2004 |
Dobrev D. "Per aspera ad astra" - Air navigation today and tomorrow: Terrestrial-based navaids & satellite-based navigation 49th Annual Air Traffic Control Association Conference Proceedings - Fall 2004. 36-40. |
0.04 |
|
1988 |
Kostadinov LN, Dobrev DD. On the structure of the C8 cubic modification of carbon Physica Status Solidi (a) Applied Research. 109. |
0.04 |
|
1982 |
Dobrev D. Ion-beam-induced texture formation in vacuum-condensed thin metal films Thin Solid Films. 92: 41-53. DOI: 10.1016/0040-6090(82)90186-9 |
0.039 |
|
2021 |
Tsuji Y, Dobrev D. Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need. International Journal of Cardiology. Heart & Vasculature. 32: 100740. PMID 33681454 DOI: 10.1016/j.ijcha.2021.100740 |
0.039 |
|
1990 |
Grantscharova E, Dobrev D. Recrystallization texture and microstructure development in silver films Physica Status Solidi (a) Applied Research. 122. |
0.039 |
|
2021 |
Betz K, Knuf F, Duncker D, Giordano M, Dobrev D, Linz D. The impact of Twitter promotion on future citation rates: The #TweetTheJournal study. International Journal of Cardiology. Heart & Vasculature. 33: 100776. PMID 33997253 DOI: 10.1016/j.ijcha.2021.100776 |
0.039 |
|
1981 |
Dobrev D, Manolov D, Vakov L. Somatotropic hormone in the serum of diabetics Internal Diseases. 20: 49-53. PMID 7257332 |
0.038 |
|
1997 |
Masheva S, Alexandrova M, Neykov S, Dobrev D. The response of introduced and local cucumber cultivars to the causal agent of powdery mildew Sphaerotheca fuliginea Acta Horticulturae. 462: 787-791. |
0.038 |
|
2017 |
Wakili R, Dobrev D. Response to: "The emerging role of hybrid ablation for ablation" by Spartialis M. et al. International Journal of Cardiology. 249: 258. PMID 29121728 DOI: 10.1016/j.ijcard.2017.09.163 |
0.038 |
|
1987 |
Tzaneva D, Dobrev D, Kanev M. Topography and microstructure of Cu-Sn coatings deposited by magnetron sputtering Thin Solid Films. 151: 235-242. DOI: 10.1016/0040-6090(87)90237-9 |
0.038 |
|
1986 |
Tzaneva DV, Dobrev DD. Crystal orientation in CuSn-alloy coatings obtained by magnetron sputtering Vacuum. 36: 605-607. DOI: 10.1016/0042-207X(86)90329-5 |
0.038 |
|
2020 |
Dan GA, Dobrev D. Polypill revisited - Unity in diversity. International Journal of Cardiology. Heart & Vasculature. 29: 100607. PMID 32885032 DOI: 10.1016/j.ijcha.2020.100607 |
0.038 |
|
1995 |
Dobrev D, Bergsträβer E, Fischer H, Andreas K. Protective effects of piracetam on hypoxia-induced inhibition of veratridine-induced [14C]-DA outflow from rat striatum Pharmacological Research. 31: 350. DOI: 10.1016/1043-6618(95)87658-8 |
0.037 |
|
2018 |
Tsuji Y, Dobrev D. Electrical storm: mechanistic and therapeutic considerations to avoid death in the survivors. Journal of Thoracic Disease. 10: S4053-S4056. PMID 30631553 DOI: 10.21037/jtd.2018.09.111 |
0.037 |
|
1977 |
Marinov M, Dobrev D. The change in the structure of vacuum-condensed hexagonal close-packed metal films on ion bombardment Thin Solid Films. 42: 265-268. DOI: 10.1016/0040-6090(77)90361-3 |
0.036 |
|
2013 |
Heijman J, Dobrev D. Pleiotropic actions of amiodarone: still puzzling after half a century. Naunyn-Schmiedeberg's Archives of Pharmacology. 386: 571-4. PMID 23568552 DOI: 10.1007/s00210-013-0865-0 |
0.036 |
|
2019 |
Dan GA, Dobrev D. Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter? International Journal of Cardiology. Heart & Vasculature. 24: 100416. PMID 31508481 DOI: 10.1016/j.ijcha.2019.100416 |
0.035 |
|
1979 |
Poppitz R, Dobrev D. Evaluation of the genetically and somatically radiation exposure of the Bulgarian population from nuclear medicine diagnostic, 1976 Radiobiologia Radiotherapia. 20: 440-447. PMID 515405 |
0.035 |
|
2003 |
Christ T, Adolph E, Schindelhauer S, Wettwer E, Dobrev D, Wallukat G, Ravens U. 112 Total IgG of patients positive for beta1‐adrenoceptor‐autoantibodies exerts beta1‐adrenoceptor‐mediated effects in rat cardiomyocytes European Journal of Heart Failure Supplements. 2: 15-15. DOI: 10.1016/S1567-4215(03)90046-4 |
0.034 |
|
2020 |
Fender AC, Dobrev D. Contemporary plaque imaging for risk stratification of coronary artery disease: Are we getting there? International Journal of Cardiology. Heart & Vasculature. 31: 100678. PMID 33294585 DOI: 10.1016/j.ijcha.2020.100678 |
0.034 |
|
1979 |
Konstantinov B, Ruseva C, Pencev V, Dobrev D. External beam gamma-therapy with large irregular fields of supradiaphragmatic lymph nodes in Hodgkin's disease. II. Dosimetric studies on a heterogenous tissue-equivalent phantom Rentgenologiya I Radiologiya. 18: 110-120. |
0.034 |
|
1991 |
Kostadinov L, Dobrev D. Plasma-assisted chemical vapor deposition of diamond from an ethanol-water-hydrogen gas mixture Surface and Coatings Technology. 47: 623-627. DOI: 10.1016/0257-8972(91)90333-R |
0.034 |
|
2001 |
Dobrev D, Vetter J, Angert N, Neumann R. Growth of iron single crystals in the etched ion tracks of polymer foils Applied Physics a: Materials Science and Processing. 72: 729-733. |
0.033 |
|
1987 |
Dobrev D, Kurtev K. STUDIES OF THE EFFECT OF BRONSTED ACIDS AND THE FORM OF THE SECOND TRANSITION METAL ON A ZIEGLER-TYPE CATALYTIC SYSTEM FOR OLEFIN DIMERIZATION Kinetics and Catalysis. 28: 872-875. |
0.032 |
|
1960 |
NIKOLOV P, POPKHRISTOV P, BOIADZHIEV T, DOBREV D. Clinical studies on anti-inflammatory and anti-allergic properties of SǔVremenna Meditsina. 11. PMID 14427241 |
0.032 |
|
1999 |
Vetter J, Dobrev D. Double metal replication of etched ion-track polymer membranes Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions With Materials and Atoms. 156: 177-182. DOI: 10.1016/S0168-583X(99)00268-2 |
0.032 |
|
2019 |
Kaya E, Siebermair J, Azizy O, Dobrev D, Rassaf T, Wakili R. Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator. International Journal of Cardiology. Heart & Vasculature. 24: 100390. PMID 31334332 DOI: 10.1016/j.ijcha.2019.100390 |
0.031 |
|
1967 |
Dimitrov M, Dobrev D, Maleev N. Structure of roentgenological studies as an index of roentgen-diagnostic activity Vestnik Rentgenologii I Radiologii. 42: 70-74. PMID 5616478 |
0.031 |
|
2012 |
Dobrev D. Review of “Analysis and application of analog electronic circuits to biomedical instrumentation” by Robert B Northrop Biomedical Engineering Online. 11: 29. DOI: 10.1186/1475-925X-11-29 |
0.031 |
|
1991 |
Grantscharova E, Dobrev D. Catalytic activity of ion-bombarded silver films Thin Solid Films. 196: 163-169. DOI: 10.1016/0040-6090(91)90184-Y |
0.029 |
|
1994 |
Pavlovska A, Dobrev D, Bauer E. Orientation dependence of the quasi-liquid layer on tin and indium crystals Surface Science. 314: 341-352. DOI: 10.1016/0039-6028(94)90236-4 |
0.029 |
|
1976 |
Dobrev D, Sahatciev A, Raicev R, Uzunov Iv.. Thorotrast induced renal carcinoma 25 years after retrograde pyelography (Bulgarian) Rentgenologiya I Radiologiya. 15: 95-100. |
0.028 |
|
1992 |
Grantscharova E, Dobrev D. Recrystallization structural effects in thin silver films Thin Solid Films. 207: 33-36. DOI: 10.1016/0040-6090(92)90097-U |
0.028 |
|
1995 |
Pavlovska A, Dobrev D, Bauer E. Facet growth of spherical lead crystals Surface Science. 326: 101-112. DOI: 10.1016/0039-6028(94)00770-5 |
0.028 |
|
1987 |
Kolarov P, Dobrev D, Ivanov I, Dobreva D. Glycosylated hemoglobin (HbA1)--an index in the control of diabetes Internal Diseases. 26: 68-73. PMID 3604200 |
0.027 |
|
1995 |
Dobrev D, Bergsträßer E, Fischer HD, Andreas K. Restriction and functional changes of dopamine release in rat striatum from young adult and old rats Mechanisms of Ageing and Development. 80: 107-119. PMID 7564562 DOI: 10.1016/0047-6374(94)01564-3 |
0.027 |
|
2021 |
Dobrev DP, Neycheva TD. Comments on “An Analog Bootstrapped Biosignal Read-Out Circuit With Common-Mode Impedance Two-Electrode Compensation” Ieee Sensors Journal. 21: 16395-16395. DOI: 10.1109/JSEN.2021.3070095 |
0.026 |
|
1971 |
Rashev M, Elenkova A, Dobrev D. Characteristics in the clinical pattern of acute myocardial infarct in patients with diabetes mellitus Internal Diseases. 10: 119-124. PMID 5156209 |
0.026 |
|
1964 |
BOGDANOV P, DOBREV D, KOSSEV R, PIRYOVA B. A METHOD OF MEASURING THE BLOOD PRESSURE OF MAN IN A WATER ENVIRONMENT Doklady Bolgarskoǐ Akademii Nauk. 17: 93-95. PMID 14168125 |
0.026 |
|
2012 |
Georgieva M, Petrova M, Dobrev D. Synthesis and investigation of chemically-deposited composite coatings Cu/SiC on polyethylene terephtalate Comptes Rendus De L'Academie Bulgare Des Sciences. 65: 1521-1526. |
0.026 |
|
2017 |
Agewall S, Camm J, Barón Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, et al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS Revista EspañOla De CardiologíA. 70: 50.e1-50.e84. DOI: 10.1016/J.RECESP.2016.11.014 |
0.025 |
|
1985 |
Dobrev D, Vlahov V, Aleksiev N. Ceftriaxone distribution in lung and bronchial tissue. I. Ceftriaxone concentration in human noninflamed lung- and bronchial tissue and blood plasma Pnevmologiya I Ftiziatriya. 22: 1-9. |
0.025 |
|
1961 |
PANDOV K, DOBREV D, ANGAROV G. Electrophoretic changes in serum proteins, its comparison with flocculation reaction and blood sedimentation in influenza patients during the course of the 1957 epidemic Nauchni Trudove Na Visshiia Meditsinski Institut, Sofiia. 40. PMID 14483507 |
0.023 |
|
2020 |
Fender AC, Dobrev D. Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis. International Journal of Cardiology. Heart & Vasculature. 100535. PMID 32399483 DOI: 10.1016/j.ijcha.2020.100535 |
0.023 |
|
1973 |
Atanasova E, Dobrev D, Indzov B. State of parodontium in patients with latent diabetes (Bulgarian) Stomatologiya. 55: 276-280. PMID 4523996 |
0.022 |
|
2020 |
Fender AC, Dobrev D. Coronary clot composition after myocardial infarction: Thrombus age matters. International Journal of Cardiology. Heart & Vasculature. 26: 100450. PMID 32142067 DOI: 10.1016/j.ijcha.2019.100450 |
0.021 |
|
1989 |
Dobrev D, Kr'stev I. A case of generalized xanthomatosis in a patient with diabetes mellitus Problemy Endokrinologii. 35: 39-41. PMID 2717573 |
0.02 |
|
2007 |
Dobrev D, Stratiev D, Kirilov K, Ivanov A. Effect of bio-ethanol quality on gasoline/bio-ethanol mixture properties Oxidation Communications. 30: 701-707. |
0.018 |
|
1961 |
TENCHEV G, KHADZHIDEKOV G, DOBREV D. Mutilating arthritis and its roentgenological characteristics SǔVremenna Meditsina. 12. PMID 13920218 |
0.018 |
|
1955 |
TOMOV L, DOBREV D. Sleep therapy of hypertension SǔVremenna Meditsina. 6: 70-75. PMID 13256339 |
0.018 |
|
1982 |
Dobrev D. Formation of texture in ion-bombarded thin metal films Vacuum. 32: 569. |
0.018 |
|
1958 |
DOBREV D. Case of acanthosis nigricans associated with gastric cancer SǔVremenna Meditsina. 9: 100-103. PMID 13615643 |
0.017 |
|
1976 |
Dobrev D, Boicheva L. Temperature dependence of the condensation of silver on glass Thin Solid Films. 32: 237-240. DOI: 10.1016/0040-6090(76)90302-3 |
0.017 |
|
1974 |
Enfedzhiev MN, Dobrev D. Postoperative complications of perineal prostatic adenomectomy Urologiya I Nefrologiya. 43-45. PMID 4138866 |
0.016 |
|
1979 |
Ruseva C, Konstantinov B, Dobrev D, Pancev V. External beam gamma-therapy with large irregular fields of supradiaphragmatic lymph nodes in Hodgkin's lymphomas. I. Clinico-dosimetric planning Rentgenologiya I Radiologiya. 18: 102-110. |
0.016 |
|
1972 |
Mitrov G, Dobrev D. Prosthesis set for radiation protection of the eye (Bulgarian) Onkologiya. 9: 188-190. |
0.015 |
|
1981 |
Dobrev D, Gittis A. Effect of incident-beam chopping on the structure of silver films condensed in a vacuum on glass Journal of Crystal Growth. 52: 159-164. DOI: 10.1016/0022-0248(81)90186-X |
0.015 |
|
1986 |
Dobrev D, Gadjokov V, Velev V, Gittis A. TEXTURE OF SILVER FILMS CONDENSED AT HIGH RATES ONTO GLASS SUBSTRATES IN VACUUM Physica Status Solidi (a) Applied Research. 95: 93-97. |
0.015 |
|
1985 |
Gittis A, Dobrev D. Development of textures during the growth of silver films condensed in vacuum on glass Thin Solid Films. 130: 335-340. DOI: 10.1016/0040-6090(85)90364-5 |
0.013 |
|
1972 |
Dobrev D, Draganov V. So-called idiopathic edema and description of a case Internal Diseases. 11: 80-84. PMID 4679934 |
0.012 |
|
1974 |
Enfedzhiev MN, Dobrev D. Early complications after perineal adenomectomy of the prostate (Russian) Urologiya I Nefrologiya. 39: 43-45. |
0.011 |
|
1987 |
Dobrev D, Krǔstev I. Case of hyperosmolar coma combined with mesenteric thrombosis Internal Diseases. 26: 105-106. PMID 3590718 |
0.011 |
|
1970 |
Kilimov N, Dobrev D. EMG investigation in a case of Acropathia ulceromutilans et deformans pseudosyringomyelitica Electromyography. 10: 317-324. PMID 5509974 |
0.01 |
|
1962 |
DOBREV D, KOSEV R, BOGDANOV P, PIRUOVA B. Studies on physiological characteristics of skin diving Izvestiia Na Instituta PO Fiziologiia. 5: 321-339. PMID 13886769 |
0.01 |
|
2021 |
Fender AC, Dobrev D. Childhood infection and modern malnutrition: Do childhood infections create an inflammatory foundation for atherosclerosis in adult life? International Journal of Cardiology. Heart & Vasculature. 35: 100840. PMID 34368418 DOI: 10.1016/j.ijcha.2021.100840 |
0.01 |
|
2010 |
Schuchardt M, Toelle M, Huang T, Wiedon A, Van Der Giet M, Mill C, George S, Jeremy J, Santulli G, Illario M, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Trimarco B, ... ... Dobrev D, et al. Sunday, 18 July 2010 Cardiovascular Research. 87: S89-S135. DOI: 10.1093/cvr/cvq176 |
0.01 |
|
2010 |
Dimova I, Hlushchuk R, Makanya A, Djonov V, Theurl M, Schgoer W, Albrecht K, Beer A, Patsch JR, Schratzberger P, Mahata S, Kirchmair R, Didie M, Christalla P, Rau T, ... ... Dobrev D, ... ... Dobrev D, et al. Saturday, 17 July 2010 Cardiovascular Research. 87: S45-S88. DOI: 10.1093/cvr/cvq174 |
0.01 |
|
1988 |
Terzieva T, Dobrev D, Petrova D. Lipoproteins in diabetes mellitus Internal Diseases. 27: 23-28. PMID 3046138 |
0.01 |
|
1983 |
Dobrev DG. Atherosclerosis - a vascular manifestation of prediabetes Klinicheskaya Meditsina. 61: 30-35. PMID 6350700 |
0.01 |
|
1981 |
Dobrev D, Angelova I, Khristov I, Zografov D. Prognostic value of the early tumor response to radiotherapy in cervical cancer Akusherstvo I Ginekologiya. 20: 154-158. PMID 7224081 |
0.01 |
|
1979 |
Dobrev DG. Somatotropic hormone, diabetes and diabetic angiopathy Internal Diseases. 18: 21-27. PMID 390884 |
0.01 |
|
1978 |
Dobrev D, Bakalov M, Zografov D. Treatment of brain tumors with BCNU Savremenna Medicina. 29: 25-28. |
0.01 |
|
1975 |
Dobrev D, Vakov L. Diabetes mellitus and arterial hypertension Internal Diseases. 14: 8-16. PMID 775787 |
0.01 |
|
1961 |
DOINOV M, DOBREV D. On some medical and medicosocial problems of the old age Naunyn-Schmiedebergs Archiv FüR Experimentelle Pathologie Und Pharmakologie. 40: 79-99. PMID 13886971 |
0.01 |
|
1960 |
DOBREV D. A case of biomycin hypersensitivity SǔVremenna Meditsina. 11. PMID 13723262 |
0.01 |
|
1957 |
NEICHEV S, DOBREV D. Effect of biomycin on the microorganisms most frequently responsible for infections SŭVremenna Medit︠S︡Ina. 8: 30-35. PMID 13506962 |
0.01 |
|
Hide low-probability matches. |